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Bacterial viruses have been an important tool for molecular biological discoveries. 
Bacteriophage λ is a bacterial virus that has been intriguing researchers for over five decades. 
But still, we are yet to answer many questions about bacteriophage λ. λ genes, O and P play an 
important role in λ replication initiation. λP outcompetes host DnaC and recruits and directs 
DnaB helicase to the λ origin of replication, oriλ.  
My study shows that λP expression is lethal to the host cell. The P-survivor cells were 
examined and were found to have chromosomal mutations. This led to the possibility that λP 
protein may be involved in elevating the level of random mutations of the host chromosome. 
These studies explore this possibility. The influence of P expression on the appearance of 
chromosomal mutations was assessed by using rifampicin resistance, and auxotrophy as 
chromosomal targets. Cellular expression of P from a cryptic λ prophage or from a ColE1-type 
plasmid was employed in this study.  
Insertional inactivation of P by recombineering knocked out P-lethality and the potential 
mutator phenotype among the 42°C survivors. The apparent mutator phenotype was also lost in 
42°C survivors upon induction of a cryptic prophage with wild-type O and an insertion in P. 
When wild-type gene P on a ColE1 plasmid was replaced by a deleted P or a mutated P (Ppi) 
gene, the rate of rifampicin resistance among the 37°C cfu was significantly lowered. These 
observations suggest that there might be a relation between P expression and the appearance of 
mutations among the P-survivors. My data also support and extend laboratory findings that two 
missense mutations in host dnaB knock out P-lethality and suppress the observed potential 
mutator phenotype. 
ColE1 plasmid loss occurred among the P-survivor cells when P was expressed from a 
ColE1 plasmid in a wild-type cell. My data suggested that the plasmid-less or cured rifampicin 
resistant mutants that arose upon thermal induction of P and the 594 rifampicin resistant mutants 
that arose in the absence of P expression were resistant to P-toxicity. However, my data showed 
that a 9 base pair deletion in the rpoB gene (mutation in rpoB confers rifampicin resistance 
 iii 
phenotype to the cells) that affected 4 amino acids was sensitive to P-toxicity which proved that 
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1.1. Summary of Genes and Regulations in Bacteriophage Lambda 
 Bacteriophage lambda is a bacterial virus which was originally obtained from a clinical 
isolate of Escherichia coli, lysogenic for this phage (Lederberg, 1951). Phage lambda, being a 
member of the lambda-like (or lambdoid) bacteriophage family, is temperate, i.e., its lifecycle 
can take either of two developmental pathways, lysis or lysogeny upon infecting a host cell. This 
is in contrast to lytic phages (eg., T1, T7, T4, etc.) that infect and muliply in the host cells 
without being able to lysogenize the cell. In the lysogenic mode, λ integrates its double stranded 
DNA into the host chromosome via site-specific recombination mechanism. λ uses positive 
control of operons by antitermination (transcription at the pR promoter past tR1 into the λ 
replication initiation genes O and P produces O and P proteins); genes that mediate early lytic 
functions are organized into divergently transcribed operons that are regulated by a single 
repressor. The repressor is encoded by a gene positioned between the two operons. All lambdoid 
phage share a common genome arrangement into functional modules that when exchanged 
within the family, produce fully functional recombinant phage (Brussow and Hendrix, 2002; 
Hendrix et al., 1999; Wrobel and Wegrzyn, 2002). Other lambdoid phages include Φ80, P22, 
434, HK97, 21, 82, 933W, HK022, LP-7, etc. (Campbell, 1971). Lambda has a double stranded 
DNA (dsDNA) genome of 48,502 base pairs and has an isometric head about 50 nm in diameter 
and a flexible tail about 150 nm long (Hendrix et al., 1983). The λ tail recognizes the receptor for 
phage λ, LamB, and the contact between the tail tip and LamB facilitates phage DNA injection 
into the host. DNA injection is followed by vegetative phage λ growth in the host. Generally 
lambda is grown on K type hosts of E. coli, but other E. coli strains can serve as hosts too.        









Figure 1. Genetic Map of Bacteriophage Lambda. The upper part of the figure shows groups of 
genes which carry out vegetative functions like phage head and tail formation; integration, 
excision and recombination; regulation; replication; late regulation and lysis. The lower part of 
the figure shows the regulatory sites and their functions. The transcriptional activity is shown by 
arrows (Echols and Murialdo, 1978). 
 
 The genes that I have been studying (O, P and cI) are grouped under regulation and 
replication in the upper part of Figure 1. In lysogeny, the phage DNA integrates into the host 
chromosome by site-specific recombination and is passively replicated as a part of the host 
DNA. λ Int protein aids in the integration of the viral DNA into the host chromosome. The 
integrated viral DNA is known as a prophage. In lysogeny, the repressor protein, CI (encoded by 
the gene cI) binds to the two operator sites, OL and OR. Binding to OR prevents the expression of 
 3 
λ replication genes, O and P from overlapping promoter, pR. Functional CI is a homodimer 
composed of two identical polypeptides, each having two domains (Ptashne et al., 1980). Three λ 
genes play a role in establishing lysogeny, cI, cII and cIII. λ genes cII and cIII assist gene cI in 
lysogenization. CII protein (97 amino acids long) acts as a transcriptional activator of three 
promoters, pE, pI and pantiQ whose expression helps in the establishment of lysogeny (Kobiler et 
al., 2002). CIII protein stabilizes the CII protein and in this way, CIII also plays an indirect role 
in establishing lysogeny. 
 Ultraviolet irradiation inactivates the repressor CI, thus, allowing the lytic cycle to 
predominate. UV induces RecA which causes cleavage of the repressor and allows the phage to 
switch from lysogeny to lysis. This is known as induction. For my experiments, I have used a 
repressor with a temperature sensitive mutation, cI[Ts]857 in order to be able to induce a 
prophage by increasing the temperature above 38°C. Upon induction of the prophage, CI is 
inactivated and λ replication initiation genes, O and P are de-repressed. λ gene product P 
“hijacks” the host replication machinery and initiates λ DNA replication. λ cro gene encodes Cro 
protein, which binds to the same operator sites as the repressor. Cro is another phage regulatory 
protein which is required for the lytic cycle to occur. Lambda has two genes, N and Q which are 
positive regulators as they promote the transcription of other λ genes (Campbell, 1971). The N 
protein promotes the maximum transcription of O and P. The Q gene product increases 
transcription of the head, tail and lysis genes. Through the action of int, xis genes, the phage 
DNA excises from the host chromosome and is then packaged into the head followed by the 
formation of intact phage particles. Phage burst is achieved by lysing the host cell – an act that 
kills the cell immediately. 
 
1.1.1. Regulation of Lytic vs. Lysogenic cycle 
 
 Phage λ can replicate by either of the two developmental pathways, lysis or lysogeny. 
Upon injecting its DNA (in double stranded linear form) into the host cell, the DNA circularizes 
through pairing and ligation of the complementary 12 bp cos sequences at either end of the 
genome (Hershey et al., 1963). Expression of a single protein, CII dictates whether the phage 
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DNA will undergo lytic cycle or lysogenize, i.e., integrate into the host cell chromosome and 
passively replicate with the host DNA. CII is known as the ‘critical lysogenic regulator’ as this 
protein plays a vital role in establishing lysogeny (Oppenheim et al., 2005). If CII is active, the 
phage DNA lysogenizes; otherwise, it goes into the lytic cycle. The activity of CII protein is 
governed by environmental factors. Bacterial protease, HflB destroys CII and this acts as a 
trigger for the phage DNA to undergo the lytic pathway of phage development and 
multiplication. Lambda CIII protein protects CII from being degraded. If CII is not degraded, it 
binds to the promoter pRE and activates the production of CI repressor which then binds to the 
operator sites, thus, establishing lysogeny. 
 Both λ CI and Cro proteins bind to the same operator sites, OL and OR. Operator 
occupancy governs the transcription from promoters, pL and pR (Ptashne et al., 1980). RecA-
mediated cleavage of the CI repressor protein makes the operator sites vacant, thus allowing Cro 
to bind to the operator sites, thus, preventing further lysogenization. Transcription from pL and pR 
drives the lytic cycle. Int and Xis proteins are transcribed from promoter, pL and aid in the 
excision of the phage DNA from the host chromosome. Following excision, almost all of the 
phage genes are expressed and help in the circularizing of the phage DNA, and packaging it into 
the phage heads. Intact phage particles are produced and the progeny bursts out of the cell. If CI 
outcompetes Cro in binding to the OL and OR operator sites, transcription from pL and pR is 
blocked, thus, repressing phage lytic growth and maintaining or promoting lysogeny (Ptashne et 
al., 1980).      
 
1.1.2. Brief Overview of λ Replication 
 
 Bi-directional replication of λ DNA involves the complexing of several phage and host 
proteins at the origin of λ replication site, oriλ which consists of four 19 bp iteron sequences 
followed by an AT-rich sequence. Transcription at the pR promoter is extended past tR1 by the 
action of the phage encoded antitermination protein N, into the λ replication initiation genes O 
and P which produces O and P proteins, respectively, which are essential for the λ replication 
initiation step.  
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 To initiate replication, first, λ replication initiator protein, O binds to the oriλ site forming 
an O-some (Dodson et al., 1989; Alfano and McMacken, 1989). This structure bends the DNA 
around itself. Another λ replication initiation protein, P outcompetes host DnaC for binding to 
host DnaB helicase and this hijacking of the host replication machinery is a vital step in the 
phage lytic cycle. The P-DnaB complex binds to the O-some, i.e., the oriλ site bound by O, 
forming oriλ-O-P-DnaB complex known as the preprimosomal complex (Dodson et al., 1989). 
The preprimosomal complex is formed by the interaction of lambda O and P proteins. Because P 
inhibits DnaB helicase activity (Biswas and Biswas, 1987), λP protein is removed from the 
complex to allow DnaB helicase to unwind the double stranded phage DNA. Activities of host 
chaperone proteins, DnaJ, DnaK and GrpE are required for the removal of P from the 
preprimosomal complex to allow DnaB helicase to function. After P removal, DnaB helicase is 
able to interact with DnaG primase and then the PolIII holoenzyme can start DNA synthesis 
(Zylicz et al., 1989).       
 λ replication is bidirectional and forms a θ structure. This is called the θ mode of lambda 
replication. After several rounds of bidirectional replication, a switch to unidirectional or σ mode 
of replication occurs, which produces linear concatemeric DNA which upon excision between 




1.1.3.   λ Replication Licensing Factor and its Role in λ Replication Initiation 
 
 Stillman coined the term replication licensing factor (Stillman, 1994). For replication of 
E. coli, DnaC protein acts as a replication licensing factor as it brings DnaB helicase to the origin 
of E. coli replication, oriC. Without DnaC mediated DnaB targeting to oriC, bacterial replication 
cannot take place. Similarly, for phage λ, the replication initiation protein P plays the role of the 
replication licensing factor as it outcompetes DnaC for binding to the host DnaB helicase and 
brings it to oriλ, thus, driving λ replication. P also needs to be removed from the site for DnaB 
helicase activity to occur.  
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 The λ replication initiation protein P is known to interact with lambda O protein 
(Tomizawa, 1971) which binds to oriλ sites (Tsurimoto and Matsubara, 1981); host proteins 
DnaB (Georgopoulos and Herskowitz, 1971; Saito and Uchida, 1977; Klein et al., 1980) required 
as a helicase for chromosomal replication; heat shock proteins DnaJ (Yochem et al., 1978), 
DnaK (Yochem et al., 1978), GrpE (Zylicz et al., 1987); DnaA (Wegrzyn et al., 1996; Datta et 
al., 2005b; Datta et al., 2005a), required for E. coli replication (acting like λO protein to bind at 
E. coli oriC); and possibly with RNA polymerase (McKinney and Wechsler, 1983). 
 
1.1.4. E. coli DnaB helicase 
           
 The hexameric DnaB protein is the E. coli primary replicative helicase (Lebowitz and 
McMacken, 1986). DnaB is composed of 470 amino acids and has a molecular weight of 52,265 
daltons (Nakayama et al., 1984a). The N-terminal domain of DnaB is involved in protein-protein 
interactions (Nakayama et al., 1984b; Lu et al., 1996). DnaB interacts with many proteins; such 
as with DnaA (Sutton et al., 1998), DnaC (Wickner and Hurwitz, 1975), DnaG (Lu et al., 1996), 
SSB (Biswas et al., 2002), the τ subunit of DNA polymerase III (Gao and McHenry, 2001), λP 
(Klein et al., 1980), P1 ban (Sclafani and Wechsler, 1981) and E. coli RNA polymerase 
(McKinney and Wechsler, 1983). DnaB forms a complex with DnaC (DnaB6-DnaC6). In the 
complex between DnaB and DnaC, DnaC acts to target DnaB to the bacterial origin of 
replication, oriC. Because DnaB and DnaC are produced at similar levels, the majority of DnaB 
in a cell is bound to DnaC (Biswas and Biswas, 1987). DnaB is capable of unwinding extensive 
stretches of double stranded (ds) DNA (Lebowitz and McMacken, 1986). By using the energy 
obtained from ATP hydrolysis, DnaB helicase promotes the propagation of replication forks 
(Lebowitz and McMacken, 1986). McMacken et al. reported that DnaB acts as a “mobile 
promoter” signal for DnaG protein (primase) to produce many RNA primers (McMacken et al., 
1977). Others (Kaplan and O'Donnell, 2002; Bujalowski, 2003) showed that DnaB can promote 
branch migration of a synthetic Holliday junction, suggesting that DnaB may be directly 
involved in DNA recombination in vivo. 
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1.1.5. Host-Phage Interactions: P-DnaB Genetics and Biochemistry 
 
 E. coli replication licensing factor, DnaC binds to DnaB helicase in a 1:1 molar ratio in 
the presence of ATP or dATP (Kobori and Kornberg, 1982a; Kobori and Kornberg, 1982b; 
Kobori and Kornberg, 1982c). 20 hexamers of DnaB are present in the cell and are known to 
form a complex with DnaC (Biswas and Biswas, 1987). λ replication initiation protein, P 
outcompetes host DnaC for binding to DnaB and directs it to oriλ (Konieczny and Marszalek, 
1995). This step is crucial for λ replication initiation. Mallory et al. showed that when a 
preformed DnaC-DnaB complex was incubated with λP protein, P-DnaB complex was formed 
and DnaC was found as a free protein (Mallory et al., 1990). This observation suggested that P 
was able to dissociate the DnaC-DnaB complex and instead, P was able to form a complex with 
DnaB. 
 Two to six monomers of λP bind to each hexamer of host DnaB protein (Mallory et al., 
1990; Osipiuk et al., 1993; Learn et al., 1997). DnaB does not unwind dsDNA. P allows DnaB to 
bind to ssDNA. Learn et al. showed that λO protein increases the ssDNA binding activity of P 
(Learn et al., 1997). It is known that λP interacts with λO protein (Tomizawa, 1971). But, in 
order to interact with or bind to O protein, P should be bound to DnaB (Alfano and McMacken 
1989; Dodson et al., 1989). But, earlier studies (Zylicz et al., 1984; Wickner and Zahn, 1986) 
indicated that O and P are able to interact irrespective of the presence of host DnaB.          
 
1.1.6. P-killing Phenotype 
 
            Rao and Rogers showed that cell killing might be caused by P-mediated titration of DnaB 
or by some unknown gene to the right of P (Rao and Rogers, 1978). This was probably the first 
time that someone demonstrated P-mediated cell killing. But, no further characterization of their 
finding was carried out. Klinkert and Klein suggested that P blocked the initiation step of E. coli 
DNA synthesis (Klinkert and Klein, 1979). They reported that host cell division was inhibited by 
P expression. But, they suggested that P expression did not kill the cells, but slowed down DNA 
synthesis. Klinkert and Klein reported that due to sequestering of DnaB by P, host cell DNA 
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synthesis was inhibited (Klinkert and Klein, 1979). In 1982, Tsurimoto et al. suggested that loss 
of cell viability and inhibition of DNA synthesis was due to overexpression of λ P gene 
(Tsurimoto et al., 1982), but no mechanisms for Klinkert and Klein and Tsurimoto et al.’s 
observations were provided. Maiti et al. also reported P-mediated host cell killing and showed 
that P-lethality was not due to the sequestration of DnaB by P (Maiti et al., 1991b). Maiti et al. 
isolated rpl (Resistant to P-Lethality) mutants (Maiti et al., 1991a) which were later found to 
have mutations in host dnaA gene (Datta et al., 2005a). These results suggested that mutations in 
host gene dnaA suppress P-lethality. Our laboratory received an rpl strain from Dr. Mandal 
which was reported to have a DnaA mutation. However, sequence analysis by our laboratory 
revealed that it did not have a DnaA mutation (Horbay, 2005). So, Horbay, 2005 was not able to 
confirm or deny whether mutations in dnaA would suppress P-interference, as she named it. 
Horbay found that P-lethality was reversible in cells exposed to P for up to five hours, so used 
the term ‘P-interference’ instead of ‘P-lethality/killing’ (Horbay, 2005).     
 
1.1.7. History of grpD55 mutations in host dnaB gene and pi mutations in λ P gene 
 
 
 GrpD55 mutations are two missense mutations in host dnaB gene and are as follows: 
 
a)   Nucleotide position: 4,263,102; Mutation: G to A;  
      Amino acid change: V256I 
b) Nucleotide position: 4,263,612; Mutation: G to A;  
      Amino acid change: E426K 
      (Horbay, 2005) 
 
 E. coli can use DnaBgrpD55 form of the protein for its replication. But, wild-type phage 
λ is not able to grow on a grpD55 cell. 
   
 Saito and Uchida showed that grpD55 mutations co-transduced with aroE at 71.5 minutes 
and they also suggested grpD as a new locus which was required for λ replication initiation 
(Saito and Uchida, 1977). Later, it was found that the grpD55 mapping was done incorrectly. 
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Bull and Hayes showed that the grpD55 allele co-transduced with malF3089::Tn10 at 91.5 
minutes (Bull and Hayes, 1996). Also, a DnaB-expressing plasmid was able to complement for 
the grpD55 mutations. This confirmed that grpD55 was an allele of dnaB (Bull and Hayes, 
1996). 
 Several host E. coli mutants do not allow the growth of wild-type λ phage (Georgopoulos 
and Herskowitz, 1971; Saito and Uchida, 1977; Georgopoulos, 1977; Sunshine et al., 1977). The 
host mutations have been mapped in three important genes required for bacterial DNA 
replication, dnaB, dnaJ and dnaK (Georgopoulos and Herskowitz, 1971; Saito and Uchida, 
1978). This phenotype has been referred to as groP- phenotype. Specific mutations in gene P 
allows λ phage growth on the groP- mutants. These compensatory mutations in gene P have been 
referred to as pi mutations (Georgopoulos and Herskowitz, 1971; Saito and Uchida, 1977; 
Georgopoulos, 1977; Sunshine et al., 1977). groPA- and groPB- are two classes of groP- mutants 
in the dnaB gene (Georgopoulos and Herskowitz, 1971). pi mutants isolated on groPA- strains are 
called piA mutants and pi mutants isolated on groPB- strains are called piB mutants. piB mutants 
grow both on groPA- and groPB- strains. But, piA mutants can only grow on groPA- strains. 
Reiser et al. reported that piB mutation is an unique kind of mutation mapping close to other piA 
mutants (Reiser et al., 1983). It is possible to estimate the number of piA mutation sites. The sites 
are scattered asymmetrically within P. The N-terminal of P protein lacks pi mutations as it is 
thought to play a role in interacting with the O protein. pi mutations lie on the C-terminal portion 
of the P protein (Reiser et al., 1983). A group of 4-5 mutants have been shown to be clustered 
around positions 392-413 while others are scattered towards the part of the P gene that 
corresponds to the C-terminus of the protein (Reiser et al., 1983). 
          
1.2. Role of Host DnaB Protein in ColE1 Plasmid Replication 
 
 The colicinogenic plasmid E1 (ColE1) was isolated from E. coli cells as a supercoiled 
DNA molecule with a molecular weight of 4.2x106 and as a supercoiled DNA-protein relaxation 
complex (Clewell and Helinski, 1969). Host DnaB helicase is known to promote the 
advancement of the replication fork in vivo (Lebowitz and McMacken, 1986; McMacken et al., 
1977). But, in case of ColE1 replication fork progression, DnaB is unable to dissociate RNA-
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DNA hybrids which results in replication fork pausing at silent ColE1 origins (Santamaria et al., 
1998). In ColE1 replication, after the formation of the initial part of the new L-strand, synthesis 
of the new H-strand begins. H-strand is synthesized discontinously in the 5’ to 3’ direction. 
Okazaki fragments of about 1000 bases are formed and are subsequenctly linked together. 
Synthesis of each DNA fragment is initiated at a short primer of RNA. The dnaG gene product 
(DNA primase) transcribes ColE1 to provide this RNA primer. The dnaB gene product acts as a 
mobile promoter which enable DNA primase to initiate transcription (McMacken et al., 1977). 
DNA polymerase III holoenzyme extends the primers. 
  
1.3.      Escaping Cell Death following λ Cryptic Prophage Induction 
 A cryptic prophage is a trapped phage DNA which has been deleted for essential λ genes. 
In my work, I used a strain called Y836 which has a cryptic λ prophage with a temperature 
sensitive (cI[Ts]857) repressor which has been deleted from int-kil and rightward from ren into 
E. coli (∆431 deletion) (Hayes, 1991) and this deletion does not allow the prophage to be excised 
from the host chromosome (as it is deleted for int and xis genes) and form intact phage particles 
upon prophage induction. Upon induction of the cryptic prophage at 42°C, λ CI repressor is 
inactivated which leads to the de-repression of the λ replication initiation genes, O and P. P 
outcompetes host DnaC for binding to host DnaB and targets it to oriλ. Replication initiation 
arises from the oriλ site in the trapped cryptic prophage, but the prophage is not able to excise 
itself from the host. This causes replicative stress in the cells, and massive cell killing. This is 
referred to as Replicative Killing and the phenotype is called RK phenotype. The cells 
harbouring the trapped cryptic prophage are designated as Replicative Killing Competent (RK+) 
cells. Approximately, 1 out of 106 cells survive this replicative stress due to host or phage 
mutations and are therefore known as Replicative killing defective (RK-) cells (Hayes and Hayes, 
1986). Hayes et al. isolated two RK- mutants (denoted as 145d and 101b) which had acquired 13 
and 14 point mutations within λ genes O and P which allowed cell survival and colony formation 
at 42°C (Hayes et al., 1998). [For details about Replicative Killing and Y836 strain construction, 
refer to Chu, 2005 and Hayes and Hayes, 1986].          
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1.4.      Auxotrophy and Rifampicin Resistance 
 Auxotrophs are mutants that are defective in a gene required to synthesize a particular 
nutrient. Therefore, they are unable to grow in a medium not supplemented with that nutrient. 
Nutrient gene products or enzymes are parts of important biosynthetic pathways required for cell 
growth. Defects in any essential nutrient gene block the synthesis of the nutrient and hence, the 
nutrient has to be supplied in the medium for the auxtrophic cell to grow. For example, a his- cell 
requires a medium supplemented with histidine to grow. For mutagenesis studies, we have used 
auxotrophy to screen for a wide variety of mutations. 
 To screen a more narrow mutation target, we screened for rifampicin resistance. 
Rifampicin resistance phenoptype is conferred by mutations in rpoB gene (4029 bp) which codes 
for the 1342-amino acid β-subunit of DNA-dependent RNA polymerase (Zillig et al., 1970). 
DNA-dependent RNA polymerase is a complex multisubunit enzyme that exists in two forms. 
RNA polymerase core enzyme has a molecular weight of 400 kDa and consists of 5 subunits, 
including an α dimer (α2), β subunit, β’ subunit and ω subunit. These subunits are converted to a 
holoenzyme following the binding of one σ subunit. RNA polymerase holoenzyme carries out 
initiation of transcription at defined promoter sites and core RNA polymerase carries out 
elongation and termination (Burgess and Travers, 1970; Burgess et al., 1969). Most of the 
catalytic functions of RNA polymerase is carried out by the β subunit which is encoded by the 
rpoB gene (Jin and Gross, 1989). Kollenda et al. obtained rifampicin resistant mutations that 
were located in 28 and 37 minutes of the E. coli chromosome standard map, some distance from 
the rpoB gene at 89.5 minutes (Kollenda et al., 1986). This is probably the only paper that 
reported rifampicin resistance mutations not linked to the rpoB gene, but was never reproduced. 
 Rifampicin antibiotic has an inhibitory effect on RNA polymerase which leads to 
inhibition of transcription. Hartmann et al. (Hartmann et al., 1967) first showed the inhibitory 
effect of rifampicin on RNA polymerase from E. coli. Later, Johnston and McClure (Johnston 
and McClure, 1976) showed that rifampicin is specifically involved in the abortive initiation of 
RNA synthesis by inhibiting the formation of the dinucleotide pppApU and the formation of the 
second phosphodiester bond. McClure and Cech (McClure and Cech, 1978) showed that the 
binding of rifampicin to RNA polymerase sterically blocks the translocation of pppApU, thus 
inhibiting further elongation of the RNA chain. It has been postulated that rifampicin competes 
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directly or allosterically with the RNA product binding site on RNA polymerase and that the 
overall inhibition of RNA synthesis by rifampicin is caused by a destabilizing effect on the 
binding of the intermediate oligonucleotides to the active enzyme-DNA complex (Kessler et al., 
1982; Schulz and Zillig, 1981; Wehrli, 1983).  
  
1.5.      Luria-Delbrück Fluctuation Test 
 The Luria-Delbrück Fluctuation Test tested two hypotheses for how mutants arise in 
bacterial cultures: the random-mutation hypothesis and the direct-change hypothesis. The 
random-mutation hypothesis predicts that the mutants appeared prior to the addition of the 
selective agent while the direct-change hypothesis predicts that the mutants appear only in 
response to the selective agent. Mutants that arose early in a generation yielded greater numbers 
of mutants in the progeny population. Luria and Delbrück used E. coli as the bacterium and 
bacteriophage T1 as the selective agent. Phage T1 kills wild-type E. coli, but mutation in tonB (a 
gene for an inner membrane protein) can make the cells resistant to phage T1 killing. If the cells 
are spread on an agar plate with the phage only, the resistant bacteria will form colonies. All 
other cells will be killed. Luria and Delbrück performed two experiments. In their first 
experiment, they started one culture of bacteria. After incubating the culture, they took out small 
aliquots and plated them with and without phage T1. This was done to measure the number of 
resistant mutants and also the total number of cells plated. The fraction of the resistant mutants 
was calculated.  
 In their second experiment, they started several small cultures. After incubation, they 
counted the number of resistant mutants and the total number of cells in each culture. It was seen 
that in their first experiment, the number of resistant mutants in each aliquot was almost the 
same. While in their second experiment, a large variation in the number of resistant cells was 
found. Some had no resistant cells and some had many. Luria and Delbrück referred to the 
cultures with a large number of resistant cells as ‘jackpot’ cultures. What they said was that the 
resistant mutants in a ‘jackpot’ culture arose in an early generation. These results proved the 
random-mutation hypothesis. While the direct-change hypothesis predicts that the results of two 
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experiments should be the same and no ‘jackpot’ cultures should appear in the second 
experiment (Luria and Delbrück, 1943; Snyder and Champness, 2003).   
 
1.6. Introductory Hypothesis for the Current Study 
 Based on the work by Chu (Chu, 2005), it was hypothesized that the overexpression of P 
can elevate the frequency of cellular chromosomal mutations over a spontaneous level seen in 
the absence of P expression. To assess the spontaneous and induced mutation frequencies, I used 
















2. Materials, Methods and Reagents 
 
2.1. Bacterial and Bacteriophage strains, and Plasmids 
 
 
2.1.1.  E. coli Strains 
 





594 F- lac-3350 galK2 galT22 
IN(rrnD-rrnE)1  
 B10 
W3350 F- lac-3350 galK2 galT22 
rpsL179 IN(rrnD-rrnE)1 
 B12 








F- lac-3350 galK2 galT22 
rpoB∆1604-1612: 
CAGGCCGTC: Pro-Gly-
Gly-Leu535-538Pro rifR  
(moved rpoB deletion from 
sc325D10 into 594) 
This work B323 
594sc125A2 F- lac-3350 galK2 galT22 




Ser512Thr rifR  
(selected from 594 at 25°C) 
594sc325E F- lac-3350 galK2 galT22 
rpoB1592: C to T: Ser531Phe 
rifR 
(selected from 594 at 25°C) 
This work B322-
594sc325E 
594sc137A2 F- lac-3350 galK2 galT22 
rpoB1586: G to A: 
Arg529His rifR 
(selected from 594 at 37°C) 
This work B322-
594sc137A2 
594sc337D F- lac-3350 galK2 galT22 
rpoB1714: A to T: Ile572Phe 
rifR 



















594::(cIII-ren)λ Tn10 [zbh29 at 17 min] bio+ 
transductant: assumed 594 
bio275 (λcIII-cI[Ts]857-ren) 





Y836 his+ SA500(λbio275 cI[Ts]857 
∆431) his+ 




∆431 O+P::Kan) his- KanR  
S. Hayes NY1153 
Y836 ilr 534c 
(RK- mutant) 
SA500 (λbio275 cI[Ts]857 




Y836 ilr 208b 
(RK- mutant) 
SA500 (λbio275 cI[Ts]857 





Y836 ilr 223a 
(RK- mutant) 
SA500 (λbio275 cI[Ts]857 





Y836 ilr 566a 
(RK- mutant) 
SA500 (λbio275 cI[Ts]857 




594[pSIM6] F- lac-3350 galK2 galT22 





al., 2007   
P514 
594[pcIpR-P-timm] F- lac-3350 galK2 galT22 






F- lac-3350 galK2 galT22 
dnaBgrpD55malF3089::Tn10 




594[pcIpR-∆P-timm] F- lac-3350 galK2 galT22 







F- lac-3350 galK2 galT22 
dnaBgrpD55malF3089::Tn10 




594[pcIpR-Ppi-timm] F- lac-3350 galK2 galT22 







F- lac-3350 galK2 galT22 
dnaBgrpD55malF3089::Tn10 





sc325A4 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1585: C to T: 
Arg529Cys rifR 
(selected from 594[pcIpR-P-
timm] at 25°C)  
This work P511-
sc325A4 
sc325A6 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1595: C to A: 
Ala532Glu rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325A6 
sc325A7 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 






timm] at 25°C) 
sc325A9 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1687: A to C: 
Thr563Pro rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325A9 
sc325A10 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1592: C to T: Ser531Phe 
rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325A10 
sc325B1 F- lac-3350 galK2 galT22 





timm] at 25°C) 
This work P511-
sc325B1 
sc325B2 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR rpoB rifR  
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325B2 






timm] at 25°C) 
sc325B6 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR rpoB rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325B6 
sc325B10 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1600: G to T: 
Gly534Cys rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325B10 
sc325C4 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1687: A to C: 
Thr563Pro rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325C4 
sc325C5 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1691: C to T: 
Pro564Leu rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325C5 
sc325C6 F- lac-3350 galK2 galT22 




rpoB1592: C to T: Ser531Phe 
rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
sc325C10 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1586: G to A: 
Arg529His rifR 
(selected from 594[pcIpR-P-
timm] at 25°C)  
This work P511-
sc325C10 
sc325D1 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1574: C to G: 
Thr525Arg rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325D1 
sc325D2 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1576: C to G: 
His526Asp rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325D2 
sc325D4 F- lac-3350 galK2 galT22 
cI[Ts]857 AmpR rpoB rifR 
(selected from 594[pcIpR-P-




sc325D5 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1527: C to A: 
Ser509Arg rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325D5 
sc325D6 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1601: G to T: 
Gly534Val rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325D6 
sc325D8 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1691: C to T: 
Pro564Leu rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325D8 
sc325D9 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1565: C to T: Ser522Phe 
rifR 
(selected from 594[pcIpR-P-
timm] at 25°C) 
This work P511-
sc325D9 
sc325D10 F- lac-3350 galK2 galT22 








timm] at 25°C) 
sc337A10 F- lac-3350 galK2 galT22 
rpoB1547: A to G: 
Asp516Gly rifR 
(selected from 594[pcIpR-P-
timm] at 37°C) 
This work P511-
sc337A10 
sc337B1 F- lac-3350 galK2 galT22 
rpoB rifR 
(selected from 594[pcIpR-P-
timm] at 37°C) 
This work P511-
sc337B1 
sc337C1 F- lac-3350 galK2 galT22 
rpoB rifR 
(selected from 594[pcIpR-P-
timm] at 37°C) 
This work P511-
sc337C1 
sc337C6 F- lac-3350 galK2 galT22 
rpoB rifR 
(selected from 594[pcIpR-P-
timm] at 37°C) 
This work P511-
sc337C6 
sc337B8 F- lac-3350 galK2 galT22 
rpoB rifR 
(selected from 594[pcIpR-P-




sc337C4 F- lac-3350 galK2 galT22 
rpoB rifR 
(selected from 594[pcIpR-P-
timm] at 37°C) 
This work P511-
sc337C4 
sc337C5 F- lac-3350 galK2 galT22 
rpoB1691: C to T: 
Pro564Leu rifR 
(selected from 594[pcIpR-P-
timm] at 37°C) 
This work P511-
sc337C5 
sc337C7 F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 
rpoB1601: G to A: 
Gly534Asp rifR 
(selected from 594[pcIpR-P-
timm] at 37°C) 
This work P511-
sc337C7 
sc337D1 F- lac-3350 galK2 galT22 
rpoB1714: A to C: Ile572Leu 
rifR 
(selected from 594[pcIpR-P-
timm] at 37°C) 
This work P511-
sc337D1 
sc337D2 F- lac-3350 galK2 galT22 
rpoB rifR 
(selected from 594[pcIpR-P-
timm] at 37°C) 
This work P511-
sc337D2 




timm] at 37°C) 
sc337D3 
sc337D6 F- lac-3350 galK2 galT22 
rpoB1609: G to T: 
Gly537Val rifR 
(selected from 594[pcIpR-P-





F- lac-3350 galK2 galT22  
cI[Ts]857 P+ AmpR 






F- lac-3350 galK2 galT22  
cI[Ts]857 P+ AmpR 






F- lac-3350 galK2 galT22  
cI[Ts]857 P+ AmpR 






F- lac-3350 galK2 galT22  
cI[Ts]857 P+ AmpR 






F- lac-3350 galK2 galT22 
cI[Ts]857 P+ AmpR 










2.1.2. Bacteriophage Strains 
 
Bacteriophage Relevant Genotype Lysate 
Collection # 
Source 
λ papa Wt 1001 Hayes, 1979 
λcI72 cI- 951 Hayes, 1979 
λvir λv2v1v3 260 Hayes, 1979 
λimm434Pam3 imm434 cI- Pam3 664 Hayes et al., 1998 
 
 
2.1.3.   Plasmids 
 
 pcI-pR-P-timm (constructed by C. Hayes) is a P-expression plasmid (ColE1-type). The 
promoter, pR drives P expression. The repressor protein, CI represses P expression at lower 
temperatures. pSIM6 plasmid contains λ Red recombination genes under λ cI[Ts]857 repressor 





2.2.  Reagents, Media and Growth Conditions 
 
2.2.1.  Solid Support Media 
a) TBA: Tryptone agar plates include 11 grams of Bacto agar, 10 grams of  Bacto tryptone and 
5 grams of NaCl per liter (Hayes et al., 2005). 
b) LBA: Luria broth plates include 11 grams of Bacto agar, 10 grams of Bacto tryptone, 5 
grams of Bacto yeast extract and 5 grams of NaCl per liter. 
c) MM: Minimal media plates include 11 grams of Bacto agar, 100 ml of 10X M9 salts a, 16 ml 
of 25% glucose, 0.1 ml of 1M CaCl2, 1 ml of 1M MgSO4.7H2O and 0.2 ml of 0.3% ferric 
citrate per liter (Arber et al., 1983). 
d) MM+his: Minimal media plates supplemented with histidine include 11 grams of Bacto agar, 
100 ml of 10X M9 salts a, 16 ml of 25% glucose, 0.1 ml of 1M CaCl2, 1 ml of 1M 
MgSO4.7H2O, 0.2 ml of 0.3% ferric citrate per liter and histidine at a final concentration of 
0.1 mg/ml. 
e) MM+his+bio: Minimal media plates supplemented with histidine include 11 grams of Bacto 
agar, 100 ml of 10X M9 salts a, 16 ml of 25% glucose, 0.1 ml of 1M CaCl2, 1 ml of 1M 
MgSO4.7H2O, 0.2 ml of 0.3% ferric citrate per liter, histidine at a final concentration of 0.1 
mg/ml and biotin at a final concentration of 1 µg/ml. 
f) MM+CA: Minimal media plates supplemented with casamino acid [not vitamin free] include 
11 grams of Bacto agar, 100 ml of 10X M9 salts a, 16 ml of 25% glucose, 0.1 ml of 1M 
CaCl2, 1 ml of 1M MgSO4.7H2O, 0.2 ml of 0.3% ferric citrate, 0.01 M Tris per liter and 0.3% 
casamino acid (1% casamino acids have also been used - mentioned with the data table). 
g) TB+Amp: Tryptone broth plates supplemented with ampicillin include 11 grams of Bacto 
agar, 10 grams of Bacto tryptone, 5 grams of NaCl per liter and ampicillin at a final 
concentration of 50µg/ml. 
h) TB+Rif: Tryptone broth plates supplemented with rifampicin include 11 grams of Bacto 
agar, 10 grams of Bacto tryptone, 5 grams of NaCl per liter and rifampicin at a final 
concentration of 100µg/ml. 
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i) TB+Kan: Tryptone broth plates supplemented with kanamycin include 11 grams of Bacto 
agar, 10 grams of Bacto tryptone, 5 grams of NaCl per liter and kanamycin at a final 
concentration of 50µg/ml. 
j) TB+Tet: Tryptone broth plates supplemented with tetracycline include 11 grams of Bacto 
agar, 10 grams of Bacto tryptone, 5 grams of NaCl per liter and tetracycline at a final 
concentration of 15µg/ml. 
k) TA: Molten TB top agar includes 10 grams of Bacto tryptone, 6.5 grams of Bacto agar and 5 
grams of NaCl per liter. 
 
a 10X M9 salts (Arber et al., 1983) 
70 grams Na2HPO4 
30 grams KH2PO4 
5 grams   NaCl 
10 grams NH4Cl 
1 liter deionized water 
 
Note: Deionized water was used in the plates. 
 
 
2.2.2. Liquid Growth Media 
 
a) TB: Tryptone broth includes 10 grams of Bacto tryptone and 5 grams of NaCl per liter. 
Deionized water is used. The broth is stirred until the ingredients dissolve, poured into 
bottles, and autoclaved for 30-45 minutes (Hayes et al., 2005). 
b) LB: Luria broth includes 10 grams of Bacto tryptone, 5 grams of Bacto yeast extract and 5 
grams of NaCl per liter. Deionized water is used. The broth is stirred until the ingredients 
dissolve, poured into bottles, and autoclaved for 30-45 minutes. 
c) SOB media (2% w/v Bacto tryptone, 0.5% Yeast extract and 10 mM NaCl)+ Mg (in 200 ml 
SOB, add 2 ml 1M MgCl2.6H2O and 2 ml 1M MgSO4.7H2O) was used for subculturing for 
making competent cells for electroporation. 
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d) SOC media (in 20 ml SOB media + Mg, add 144 µl of 25% glucose – final concentration of 
glucose is 1.8µg/ml) was added to the electroporated/pulsed cell-DNA mixture. 
 
 The liquid cultures were incubated in a shaking water bath adjusted to the desired 





a) A stock of 50 mg/ml ampicillin is used. 50 mg of ampicillin sodium salt was dissolved in 
1 ml of sterile water and was mixed well until ampicillin was dissolved. The stock 
solution was filter sterilized and was stored in -20°C. 1 ml of 50 mg/ml ampicillin was 
added to 1 liter of media to get a final concentration of 50µg/ml (Miller, 1992).  
b) A 50 mg/ml stock of rifampicin is used. 100 mg of rifampicin was dissolved in 2ml of 
methanol. Approximately, 5 drops of 10N NaOH was added to facilitate the antibiotic to 
dissolve. The stock solution was filter sterilized and the container (eppendorf tube) was 
wrapped with a foil as rifampicin is light-sensitive. 2 ml of 50 mg/ml rifampicin was 
added to 1 liter of media to get a final concentration of 100µg/ml. Freshly made 
rifampicin stock was added to the media and also freshly made media plates 
supplemented with rifampicin were used for the experiments (Miller, 1992).  
c) A stock of 50 mg/ml kanamycin is used. 100 mg of kanamycin was dissolved in 2 ml of 
sterile water and was mixed well until kanamycin was dissolved. The stock solution was 
filter sterilized and stored in -20°C. 1 ml of 50 mg/ml kanamycin was added to 1 liter of 
media for final concentration of 50µg/ml (Miller, 1992).  
d) A stock of 15 mg/ml tetracycline is used. 15 mg of tetracycline is dissolved in 0.5 ml of 
concentrated ethanol and 0.5 ml of sterile water. The container (eppendorf tube) is 
wrapped with a foil. 1 ml of 15 mg/ml tetracycline was added to 1 liter of media for final 





2.2.4.   Buffers 
a) Φ80 buffer (0.01 M Tris pH 7.6 and 0.1 M NaCl) was utilized for cell culture and phage 
dilutions (Hayes et al., 2005).  
b) TE buffer (0.01 M Tris-HCl pH 7.6-8 and 0.01 M Na2EDTA) was used for storage of 
DNA.  
c) TE* buffer (0.01 M Tris-HCl pH 7.6-8 and 0.001 M Na2EDTA) was used for 
manipulation of DNA (Hayes et al., 2005).  
d) TBE buffer (1 M Tris pH 8, 1 M Boric acid and 0.02 M Na2EDTA) was used to make 




2.3.  Methods and Protocols in Molecular and Microbial Genetics 
  
2.3.1.   Plasmid DNA Isolation 
 Plasmid DNA was isolated using EZ-10 Spin Column Plasmid DNA Kit (BioBasic) and 
QIAprep Spin Miniprep Kit (50) – Cat. No.: 27104 (Qiagen), as per included instructions. 
 
2.3.2.   DNA Agarose Gel Electrophoresis 
 0.8% agarose gels were made using TBE buffer and agarose (purchased from Sigma). 
Gels were run at approximately 90 V for up to 1.5 hours. DNA band sizes were estimated using a 
1 Kb DNA ladder purchased from Invitrogen. The 1 Kb DNA ladder produces DNA bands at 10 
Kb, 8 Kb, 6 Kb, 5 Kb, 4 Kb, 3 Kb, 2 Kb, 1.5 Kb, 1 Kb and 0.5 Kb. The ladder contains 
equimolar mixtures of each fragment, and was utilized to estimate the mass of unknown DNA 




2.3.3.   Preparing Competent Cells and Transformation of E. coli 
 A log phase subculture was pipetted into an eppendorf tube and was centrifuged for 2 
minutes at 12 K. The supernatant was discarded and the cell pellet was gently resuspended in 
one-half of the original volume of 0.01M NaCl. The resuspended cell-NaCl mixture was 
centrifuged as before. The supernatant was discarded and the pellet was gently resuspended in 
one-half of the original volume of 0.03M CaCl2. The tube was held on ice for 30 minutes. 
Centrifuging was done as before. The supernatant was discarded and the cell pellet was gently 
resuspended in 1/10th of the original volume of 0.03M CaCl2. The cells are now competent for 
transformation and were held on ice (for a very short period). 0.2 ml of the competent cells was 
mixed with 5 µl of the plasmid DNA. The cell/DNA mixture was held on ice for 60 minutes and 
then, heat shocked at ~42-43°C for 90 seconds in a heat block. The cell-DNA mixture was 
chilled on ice for 2 minutes and then, 800 µl of TB was added to the transformation mixture to 
make the total volume ~1 ml. The solution was incubated for ~1½ hours in a 25°C or 30°C 
shaking water bath (as per requirement) with very slow and gentle shaking. The transformation 
mixture was diluted and plated on TB+50µg/ml Amp selection plates. In most cases, the 
transformation mixture was also plated on rich TB plates for determining the frequency of 
appearance of AmpR transformants. Incubation was done at 25°C or 30°C depending on the cell 
type. Incubation varied from 48-72 hours depending on the growth rate of the transformants.  
 
2.3.4.   Restriction Digestion Analysis 
 All restriction enzymes were purchased from New England Biolabs (NEB) and used as 
directed. 
 
2.3.5.   Strip Streaking of Phage for Single Plaques 
 0.3 ml of host cells mixed with 3 ml of warm tryptone top agar was plated onto a rich 
tryptone agar plate. The agar was allowed to solidify for 10-15 minutes. With a pipette, 0.05 ml 
(or, a lesser volume) of phage lysate was dropped close to the edge of the plate lawn (spot phage 
lysate labelled in Figure 2). Using autoclaved paper strips, streaking was performed as indicated 
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in Figure 2 below. A fresh paper strip was used for each strip 1, 2, 3 and 4. The 4th paper strip 
was used 3 times; 4a, 4b and 4c as shown in Figure 2 below. Only the edge of the spot phage 
lysate or end of previous strip, for 1, 2 and 3 was touched. Strip 4 was run across the stripped 
area of 3 as illustrated in the figure below. This method is a fast way of obtaining single plaques 









Figure 2. Strip Streaking of Phage for Single Plaques. The small ellipse in the figure 
represents the spot phage lysate and the rectangles represent the path used to dilute the spotted 






2.3.6.   Preparation of a Standard Phage Lysate 
 20 ml LB was pipetted into a 125 ml culture flask. 200 µl of 1M MgCl2, 200 µl of 1M 
Tris-HCl (pH 7.5) and 200 µl of 1M CaCl2 (each at 0.01M final concentration) were added to 
LB. One flask was made per lysate. The flask was kept in a 39°C air incubator for pre-warming. 
An individual (single; i.e., one) plaque was picked using a glass 5” pipette attached to a pipetter 
aid and was suspended into 0.5 ml of Φ80 buffer in a 1.5 ml eppendorf tube. (The top of the 
pipetter aid should be raised before coring the isolated plaques.) The solution was pipetted up 
and down several times to ensure that the plaque was submerged in the buffer. The plaque-buffer 
was incubated for ~15 minutes in 39°C air incubator. The eppendorf tube was centrifuged at 13K 
for 2 minutes and then, the top 0.4 to 0.5 ml was carefully decanted. While the plaque-buffer 
solution is incubating, 0.3 ml overnight cell culture was mixed with 20 µl of 1M MgCl2, 20 µl of 
1M CaCl2 and 20 µl of 1M Tris-HCl (pH 7.5) in another 1.5 ml eppendorf tube. The 0.4 to 0.5 
ml of phage-plug eluate was added to the above mixture and the resulting solution was gently 
vortexed and then, the solution was incubated for 15 minutes in a 37°C air incubator. The 
cell/phage-eluate mixture was added to the 20 ml LB that was pre-warming at 39°C. The flask 
was placed in a 39°C shaking water bath (speed at 4.5) and was incubated for 3 to 6 hours. The 
mixture was monitored for cell growth and lysis. The lysate was poured into a 30 ml Corex tube 
and was spun at 8 to 10K for 10 minutes. The supernatant was decanted into a sterile bottle 
containing 0.3 ml chloroform (to kill any contaminating cells). The bottle was shaken and was 
stored in the refrigerator/cold box. The phage was titered to determine the number of pfu/ml.    
 
2.3.7.   Streaking of Bacterial Cells for Single Colonies 
 Method 1: A loopful of bacterial cells was streaked on top of an agar plate (concentrated 
cells labelled in Figure 3). After sterilizing the loop, vertical streaks (patch 2 in Figure 3) were 
made across the concentrated cells as shown in the figure below. The loop was sterilized again. 
Then, a horizontal streak 3 was made across patch 2. After sterilizing the loop again, a vertical 
streak 4 was made across the horizontal streak 3. The loop was sterilized. Finally, streaks were 
made across vertical streak 4 (see Figure 3) to obtain isolated single colonies. This technique is a 









Figure 3. Streaking of Bacterial Cells for Single Colonies (Method 1). Rectangles 1 and 2 
represent patch of cells. Lines 3 and 4 represent streaks in the direction of the arrows.  
 
 Method 2: A loopful of bacterial cells was streaked on top of an agar plate (as in Method 
1). After sterilizing the loop, a downward vertical streak was made across the concentrated cells. 
The loop was flipped or turned to the other side and multiple streaks were made throughout the 
plate across the vertical streak to obtain isolated single colonies. This method is quicker than 
Method 1 as less sterilization steps are needed. 
 
2.3.8.   Cross Streaking Immunity Assay 
 The loop was initially flamed for sterilization. After cooling the loop in agar (6-8 stab 
times), a loopful of λcI72 phage was applied as a vertical streak about a 1/3rd of the way across 
the plate. After flaming the loop and cooling it, λvir was applied as a parallel streak 2/3rd of the 
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way across the plate. The lysate solutions were allowed to dry on the agar surface by opening the 
lids slightly. After loop sterilization, a single colony of a cell was touched and was streaked 
(about 1 inch) across the dry streak of λc172. The steps were repeated for the dry streak of λvir. 
The plates were incubated at 30°C for 16 hours (or, overnight). For each single colony assayed, 
the above steps were repeated (Figure 3). After the incubation period, it was noted whether the 
streaked cells had been lysed by the phages. 
 Also, using a sterile loop, a single colony of the cell was touched and then the cell was 
streaked on two fresh TB plates (labeled 30°C and 42°C). These plates were then incubated at 
their labeled temperatures for 16 hrs (or, overnight). The growth of the cells at 30°C and 42°C 






Figure 4. Cross Streaking Immunity Assay. The vertical lines represent streaks of λcI72 and 
λvir phages. Phage λcI72 lyses non-lysogenic cells. Lysogenic cells are immune to λcI72. Both 
lysogens and non-lysogens are lysed by phage λvir.         
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2.3.9.   Stab Assay for Auxotrophy and Plasmid Retention 
 Colonies arising on rich TB plates at 30°C were picked with sterile toothpicks and were 
stabbed onto minimal media plates. The stabbed minimal media plates were incubated at 30°C to 
check whether any spontaneous auxotrophs arose within the starting assay cells. Similarly, the 
colonies arising on rich TB plates at 42°C were picked with sterile toothpicks and stabbed onto 
two minimal media plates. One plate was incubated at 30°C and another at 42°C (to determine 
whether the mutations are temperature sensitive). In both the above cases, stabbing was also 
done on rich TB plates to ensure transfer of cells. The incubation time is 48 hours. Potential 
auxotrophs were picked from the TB control plate and streaked onto a minimal media plate for 
auxotrophy confirmation. Streaking was also done on a minimal media plate supplemented with 
biotin to find out if the mutants were biotin auxotrophs.    
 Note: Histidine was added to minimal media plates for Y836 his- and Y836 his- derived 
cells. 
 Colonies that arose on rich TB plates at 25°C, 30°C, or 37°C were stabbed onto 
TB+50µg/ml Amp plates using a sterile toothpick to test ampicillin resistance, i.e., evidence cells 
carry a plasmid. In the above case, stabbing was also done on rich TB plates to ensure transfer of 
cells. The plates were incubated at 25°C for 48-72 hours. 
 
2.3.10. Replicative Killing Assay 
 RK+ cells were tested for their ability to plate at equal efficiency on rich TB agar, 
minimal media agar supplemented with histidine (MM+his), and minimal media plates 
supplemented with casamino acid (MM+CA) at 30°C. At this temperature, the prophage genes 
remain repressed and therefore, there is no replicative killing of the cells. A late log phase or 
almost stationary phase culture was centrifuged in a Corex centrifuge tube at 5K for 5 minutes. 
The supernatant was discarded. The pellet was resuspended in 10 ml of Φ80 buffer and was re-
centrifuged at 5K for 5 minutes. The rich media supernatant was discarded. The pellet was 
resuspended in 2 ml of Φ80 buffer (100 culture dilution). Then, the culture was diluted and plated 
on rich TB, minimal media plates supplemented with histidine and minimal media plates 
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supplemented with casamino acid at 10-7 and 10-8 plating dilutions. The plates were incubated at 
30°C for 48 hrs. The titers obtained are used as a control for the next assay to find the extent of 
cell killing at 42°C. 
 For this assay, the same procedure (mentioned above) was followed using the overnight 
culture and plating was done at 10-1, 10-2 and 10-3 plating dilutions. The plates were prewarmed 
for 2 hours and incubated at 42°C for 48 hours. The RK- frequency and the extent of cell killing 
was found using the cell titer at 42°C and the control cell titer at 30°C. 
 
2.3.11. Re-repression Assay 
 594[pcIpR-P-timm] cells were grown in TB containing ampicillin at a final concentration 
of 50µg/ml at 25°C for ~40-44 hours (to stationary phase). 2 ml of the cells was centrifuged at 
6K for 6 minutes in a 15 ml Corex tube. The supernatant was discarded and the cell pellet was 
resuspended in 2 ml of Φ80 buffer. The diluted cells were plated at 25°C, 30°C and 37°C on TB 
plates. Incubation periods were ~48 hours for 30°C and 37°C plates, and ~72 hours for 25°C 
plates. There were 3 other sets of plates on which diluted cells were plated which were initially 
incubated at 37°C for 1 hour, 2 hours and 6 hours and then, were shifted to 30°C. Before shifting 
the plates to 30°C, the plates were cooled on ice. All the plates that were incubated at 37°C were 
prewarmed for ~3½ hours. The total incubation period for the plates that were incubated at 37°C 
for 1, 2 and 6 hours and then, were shifted to 30°C was ~48 hours.         
 The colonies that arose on rich TB plates at 25°C, 30°C, 37°C and 37°C plates shifted to 
30°C were picked with sterile toothpicks and were stabbed onto 2 plates, namely, TB+Amp and 







2.3.12. Low Dose Inoculum Assay (LDIA) 
 A culture from a single colony of 594[pcIpR-P-timm] cells was grown (in TB 
supplemented with ampicillin at a final concentration of 50µg/ml) at 25°C in a shaking water 
bath. 0.5 ml of the stationary phase culture of 594[pcIpR-P-timm] cells was diluted to 10-7 
culture dilution in Φ80 buffer. 0.1 ml aliquots from the 10-7 culture dilution (i.e., 10-8 plating 
dilution) were added to each of the 40 tubes containing 1 ml of TB. The diluted cells added to the 
tubes were also plated on TB plates which were incubated at 30°C or 25°C to find out the 
tentative number of cells added to each tube. All 40 tubes were allowed to shake at 25°C for 48 
hours at a high speed until there was visible cell growth. All 40 tubes had growth to stationary 
phase. The tubes were vortexed well and 0.1 ml of the cells (10-1 plating dilution) from each tube 
was plated on two TB+100µg/ml Rif plates. One plate was incubated at 25°C and the other at 
37°C. Cells from a few tubes were titered on TB plates at 25°C and 37°C and their average titer 
was used to determine the frequency of rifampicin resistance at 25°C and 37°C for all cultures. 
The 37°C plates were prewarmed for 2 hours. The plates at 37°C were incubated for 48 hours 
and the ones at 25°C were incubated for 72 hours. 
 For 594 cells, 0.5 ml of a stationary phase overnight culture was diluted to 10-7 culture 
dilution in Φ80 buffer. 0.1 ml aliquots from the 10-7 culture dilution (i.e., 10-8 plating dilution) 
were added to each of the 4 tubes containing 1 ml of TB. The diluted cells added to the tubes 
were also plated on two TB plates to find out the tentative number of cells added to each tube. 
One of the spread plates was incubated at 25°C and the other was incubated at 30°C for 48 hours. 
All 4 tubes were allowed to shake at 30°C for 48 hours until there was visible cell growth. All 4 
tubes had growth to stationary phase. After vortexing each culture tube, 0.1 ml of the cells (10-1 
plating dilution) from each of the 4 cultures was plated on two TB+100µg/ml Rif plates. One 
plate was incubated at 25°C and the other at 37°C. Two tubes having cell growth were titered on 
TB plates to determine the frequency of rifampicin resistance at 25°C and 37°C. The 37°C plates 





2.3.13. Isolation of Independent Rifampicin Resistant Mutants 
 One rifR mutant (that arose from a rifS cell, 594[pcIpR-P-timm]) from each culture tube 
of Low Dose Inoculum Assay was streaked or stabbed on fresh TB+100µg/ml Rif plates at 25°C 
for confirmation of rifampicin resistance. Incubation period was 48-72 hours depending on cell 
growth. Some cells took more time to grow on fresh TB+Rif plates than others. 
 For 594 rifR mutants, one rifR mutant (that arose from wild-type 594 cells) from each 
culture tube was streaked for single colonies on a TB+100µg/ml Rif plate which was then, 
incubated at 25°C for 48 hours. 
 
2.3.14. Phage Plating Technique 
 0.1 ml of the phage lysate was diluted in Φ80 buffer and was plated on a rich TB plate 
with 0.3 ml of the host cells and 3 ml of warm tryptone top agar. The plates were incubated 
overnight at 30°C or 37°C.    
 
2.3.15. Cell Spreading Technique 
 A volume of the overnight culture was centrifuged at 6K for 6 minutes and the 
supernatant was discarded. The cell pellet was resuspended in the same volume of Φ80 buffer 
(100 culture dilution). The cells were then diluted and plated on media plates as per requirement. 
 
 
2.3.16. Preparation of Competent Cells and Electroporation of DNA into E. coli 
 
 A single colony of 594[pSIM6] was picked and inoculated in 10 ml TB containing 
ampicillin at a final concentration of 50µg/ml. The culture was shaken at 30°C overnight. A 
small volume of the overnight culture of 594[pSIM6] cells was subcultured in a volume of SOB 
media + Mg and was shaken at ~30°C for ~4 hours to mid-log phase. An aliquot of the 
subculture was centrifuged at 6K for 6 minutes (1X wash) in a Corex tube. The supernatant was 
discarded and the cell pellet was resuspended in the same volume of Φ80 buffer. 0.1 ml of the 
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resuspended cells was plated on TB+Rif plates (10-1 plating dilution). The cells were also diluted 
and plated on TB and TB+Amp plates (10-7 plating dilution). This was done to determine the 
initial number of AmpR 594[pSIM6] cells present in the subculture. The rest of the 594[pSIM6] 
subculture was transferred to a 42°C shaking water bath and was incubated for 15 minutes with 
slow shaking. The flask containing cells was then swirled in an ice bath and was allowed to sit in 
the ice bath for 5 minutes. 10 ml aliquot of the cells was taken into a cold 30 ml Corex tube. The 
cells were centrifuged at 7K for 7 minutes. The supernatant was discarded. 1 ml of ice cold 10% 
glycerol was added/tube to the cell pellet (obtained by centrifuging 10 ml cells). The mouths of 
the tubes were sealed with parafilm and the pellet was resuspended by rolling the tube gently. 
When the pellet was resuspended, an additional 10 ml of ice cold 10% glycerol was added/tube 
and the cells were mixed gently. The cells were centrifuged again at 7K for 7 minutes. The 
supernatant was discarded. 1 ml ice cold 10% glycerol was added/tube to the cell pellet. The 
mouths of the tubes were sealed with parafilm and the pellet was resuspended by rolling the tube 
gently. The samples were then pipetted into cold 1.5 ml eppendorf tubes (cooled to -20°C) and 
were centrifuged at 12K for 1 minute. The supernatant was discarded and the pellet was 
resuspended in 100µl final volume of ice cold 10% glycerol. The cells were mixed by finger 
tapping. The cells are then competent for electroporation. 50µl of the competent cells was mixed 
with 2.5µl of the rpoB DNA containing the mutation (actual rpoB PCR product sequenced was 
used). The cell-DNA mixture was pipetted into a cold electroporation cuvette (cooled to -20°C 
before use) and the cuvette was put into an electroporator and the mixture was pulsed. 
(Electroporator was warmed up for a while before use.) A blank was also pulsed which only had 
cells and no DNA (control). After pulsing, the TC and kV values were recorded for each 
electroporation. Immediately after pulsing, 1 ml of SOC media was added to the mixture in the 
cuvette and the whole mixture+SOC was immediately pipetted out into a 2 ml eppendorf tube 
(cooled to -20°C before use). The tube was immediately incubated in a 30°C shaking water bath 
and shaken gently at a very low speed for ~3 hours. Then, a small volume of electroporated 
mixture was pipetted into an eppendorf tube and centrifuged at 12K for 2 minutes. The 
supernatant was discarded and the cell pellet was resuspended in the same volume of Φ80 buffer 
(100 culture dilution). This step was done to remove the rich SOC media. Plating was done on 
TB+100µg/ml Rif selection plates (blank was also plated). TB plating for blank and at least one 
strain were done as controls. Incubation of all plates was done at 30°C for ~48-62 hours. 
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2.3.17. P Complementation Assay 
 
 The phage λimm434Pam3 has an amber mutation in P and therefore, it only grows on 
host cells which can complement for P or on a nonsense suppressor strain a like TC600. 594 has 
been used as a negative control for this assay while suppressor strain, TC600 has been used as a 
positive control. 
 0.1 ml of the λimm434Pam3 phage lysate was diluted in Φ80 buffer and was plated on a 
rich TB plate with 0.3 ml of the host cells and 3 ml of warm tryptone top agar. The plates were 
incubated overnight at 37°C or 30°C (as per requirement). For determining P expression from 
plasmid containing cells, the cells were grown in TB containing ampicillin at a final 
concentration of ~50µg/ml in a ~25°C shaking water bath for ~48 hours.  
 
a
 Nonsense suppressor strain: A bacterial strain / cell which has a mutation within the anticodon 














3.1.   P-killing and the involvement of host DnaB helicase 
 
 Viability of E. coli cells upon λP expression was studied in this work. The involvement 
of host DnaB helicase in P-killing was not clear. λP is known to outcompete host DnaC for 
binding to DnaB helicase and this hijacking of the E. coli replication machinery by 
bacteriophage λ might explain cell killing upon P expression. In order to study cell killing upon 
P expression, the following P-expression systems were employed: 
 
a)   P-expression from a cryptic λ prophage: 
 Upon shifting cells containing the cryptic λ prophage and expressing wild-type P from 
30°C to 42°C, cells were killed at a high frequency (Figure 5 and Supplemental Table 2). Y836, 
Y836 his+, 594::(cIII-ren)λ and Y836 ilr O223aP+ are wild-type P-expressing strains which all 
exhibited cell killing at 42°C. Insertional inactivation of P in Y836 O+P::Kan cells and IS2 
insertion in P in Y836 ilr O+P::IS2 cells suppressed cell killing at 42°C which suggested that 
some level of P-expression was toxic/lethal to the cells. GrpD55 mutations in DnaB suppressed 
cell killing in spite of P being expressed from the cryptic λ prophage. This suggested that P-








Figure 5. Cell survival at 42°C w.r.t. 30°C 



































































Figure 5. Cell survival at 42°C w.r.t. 30°C. Assay cell cultures were washed and the cell pellets 
were resuspended in Φ80 buffer. The cells were diluted and plated on rich TB plates in 
duplicates that were incubated at 30°C and 42°C. Viability at 42°C w.r.t. 30°C = Cell titer on TB 
at 42°C / Cell titer on TB at 30°C. [See actual data in Supplemental Table 2.] 
 
b)    P expression from a plasmid: 
 594[pcIpR-P-timm] cells were killed by an approximately 200 fold when shifted from 
25°C to 37°C (Figure 6 and Supplemental Table 3). At 37°C, only trace amounts of P was 
expected to be expressed from the plasmid because there was leaky expression of P at 37°C even 
when the CI repressor was active. This was probably because the plasmid system used had only 
the OR operator and therefore, the P-expression system was not tight. The repressor, CI functions 
tightly when both OL and OR operators are present (Ptashne et al., 1980). Also, unpublished data 
from our laboratory showed that phage λcI72 did not grow on a 594 strain containing a P-
expression plasmid under a cI[Ts]857 repressor (594[pcIpR-P-timm] cells) at 37°C which 
suggested that the repressor, CI was still active at 37°C. GrpD55 mutations in DnaB suppressed 
the cell killing phenotype which suggested that P-DnaB interaction was essential for P-killing. 
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Figure 6. Cell survival at 37°C and 30°C w.r.t. 25°C 























Figure 6. Cell survival at 37°C and 30°C w.r.t. 25°C. Assay cells were washed and the cell 
pellets were resuspended in Φ80 buffer and were diluted. The diluted cells were plated on rich 
TB plates that were incubated at 25°C, 30°C and 37°C. Viability at 30°C or 37°C w.r.t. 25°C = 
Cell titer on TB at 30°C or 37°C / Cell titer on TB at 25°C. [See actual data in Supplemental 
Table 3.] 
 
3.2. Determining whether the cells can recover, i.e., start growing when P is removed from 
the cells  
 
 Host cells are killed upon P expression (Section 3.1). It was asked whether P inhibits 
cells from growing or does P kill the cells. 2 ml of 594[pcIpR-P-timm] stationary phase cells 
were centrifuged at 6K for 6 minutes in a Corex tube and the cell pellet was resuspended in the 
same volume of Φ80 buffer. The diluted cells were plated at 25°C, 30°C and 37°C on TB plates. 
Incubation period was ~48 hours for 30°C and 37°C plates and ~72 hours for 25°C plates. There 
were 3 other sets of plates on which diluted cells were plated which were initially incubated at 
37°C for 1 hour, 2 hours and 6 hours and then, were shifted to 30°C. Plasmid retention was 
determined by stab assay of the colonies arising on rich TB plates at 25°C, 30°C, 37°C and 37°C 
plates shifted to 30°C. Upon shifting the 594[pcIpR-P-timm] cells from 37°C to 30°C after 1 or 2 
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hours, the cells were able to recover from the P-stress and start to grow again. 6 hours of cellular 
exposure to P and then shifting cells back to 30°C decreased viability by 150-fold and plasmid 
retention by about half (Figures 7 and 8 and Supplemental Table 4). So, it can be inferred that 
after a certain period of cellular exposure to P, cells are not able to grow even if they are shifted 
back to a permissive temperature. But, shorter P exposures prevent cell growth, but upon shifting 
to 30°C, cell starts growing again. Hence, P-lethality can be renamed as P-inhibition (Horbay, 
2005). 
 
Figure 7. Re-repression (of P) assay – analysis of viability 































Figure 7. Re-repression (of P) assay – analysis of viability. A volume of stationary phase cells of 
594[pcIpR-P-timm] were washed and the cell pellet was resuspended in the same volume of Φ80 
buffer. The diluted cells were plated on TB plates that were incubated at 25°C, 30°C and 37°C 
(controls). 3 sets of plates were also plated with the same cells at 37°C which after 1, 2 and 6 
hours, respectively were cooled on ice for a while and were then shifted back to 30°C. Viability 
on rich TB plates was noted after the incubation period. Viability of cells at 25°C, 30°C or 37°C 
= Cell titer (cfu/ml) at 25°C, 30°C or 37°C / Cell titer (cfu/ml) at 25°C. Viability of cells after 
shifting 37°C plates to 30°C after 1 or 2 or 6 hours = Cell titer (cfu/ml) after shifting 37°C plates 
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to 30°C after 1 or 2 or 6 hours / Cell titer (cfu/ml) at 25°C. [See actual data in Supplemental 
Table 4.] 
 
Figure 8. Re-repression (of P) assay – analysis of plasmid retention 


































Figure 8. Re-repression (of P) assay – analysis of plasmid retention. A volume of stationary 
phase cells of 594[pcIpR-P-timm] were washed and the cell pellet was resuspended in the same 
volume of Φ80 buffer. The diluted cells were plated on TB plates that were incubated at 25°C, 
30°C and 37°C (controls). 3 sets of plates were also plated with the same cells at 37°C which 
after 1, 2 and 6 hours, respectively were cooled on ice for a while and were then shifted to 30°C. 
Cfu obtained at different temperatures on rich TB plates were picked with a sterile toothpick and 
stabbed onto a rich TB plate supplemented with ampicillin at a final concentration of 50µg/ml 
and also on a TB control plate. Incubation of the stabbed plates was done at 25°C. % plasmid 
retention among cfu that arose at a particular temperature = (Number of cfu that were able to 





3.3. Preliminary results of Chu (Chu, 2005) that were reproduced in this work 
 
3.3.1.   Efficiencies of plating of starting RK+ cells at 30°C and rare RK- mutants at 42°C on 
rich TB and minimal media (MM) agar plates 
 
 Chu showed that auxotrophs arise at a very high frequency among the RK- mutants and 
the auxotroph formation is linked to λ gene expression (Chu, 2005). Y836 cells containing the 
cryptic λ prophage are Replicative Killing competent (RK+) cells. Y836 his+ transductants were 
constructed by transducing the his+ allele into Y836 cells (Chu, 2005). The cryptic λ prophage 
was transduced into wild-type 594 cells (Chu, 2005) and the resultant λ+ transductants, i.e., 
594::(cIII-ren)λ were also RK+ cells. Upon cryptic λ prophage induction in Y836, Y836 his+ and 
594::(cIII-ren)λ, RK- mutants arose on minimal media (MM) agar plates at a lower frequency 
than on rich TB plates (Table 2). This was assessed by comparing the cell titers on MM and rich 
TB plates at 42°C after centrifuging the cultures at 6K for 6 minutes and resuspending the cell 
pellet in the same volume of Φ80 buffer. The resuspended cells were diluted and plated on rich 
TB and MM plates at 30°C and 42°C. Table 1 shows control 30°C cell titer data, and the titers of 
the starting cells were roughly the same on both MM and TB plates at 30°C. This assay is of 
utmost importance because the current study depends on the validity of the results obtained by 
Chu (Chu, 2005). Hence, these assays were reproduced and as expected, they yielded the same 

















Table 1. Efficiency of plating of assay strains on rich (TB) and minimal medium (MM) at 
30°C  
 
Strain Experiment # Titer on TB at 
30⁰C a 
Titer on MM 
at 30⁰C a 
Titer on TB / 




1 2.6 x 108 7.4 x 108 0.35 Y836 his- 
(MM+his plates 
used) 
2 1.71 x 109 1.64 x 109 1.04 
0.7 ± 0.35 b 
Y836 his+ 1 1.5 x 109 1.5 x 109 1 1 
1 1.6 x 109 1.2 x 109 1.33 
2 1.6 x 109 1.5 x 109 1.07 
3 5.6 x 108 5.7 x 108 0.98 
594::(cIII-ren)λ 
4 1.4 x 109 1.64 x 109 0.85 
1.06 ± 
0.101 
594 1 1.2 x 109 1.3 x 109 0.92 1.08 
  
a
 Assay cells were plated on rich TB and MM (or, MM+his for Y836 his- cells) agar plates at 
30°C and the cell titers on the above plates were determined. 
b








Table 2. Frequency at which RK- mutants arose on rich TB and MM agar plates at 42°C 
 
Strain Experiment # RK- frequency at 42°C a Frequency on 





  TB MM   
1 1.69 x 10-5 8.65 x 10-7 20 
2 1.12 x 10-5 7.3 x 10-7 15 
3 1.35 x 10-5 8.65 x 10-7 16 
4 1.65 x 10-5 1.05 x 10-6 16 





6 1.27 x 10-6 2.41 x 10-7 5 
12.7 ± 2.7 
1 1.27 x 10-5 1.27 x 10-6 10 
2 1.67 x 10-5 2.53 x 10-6 7 
3 1.47 x 10-5 2.47 x 10-6 6 
Y836 his+ 
4 1.33 x 10-5 1.2 x 10-6 11 
8.5 ± 1.2 
 
a
 Assay cells were plated on rich TB and MM agar plates at 42°C. Survivors at 42°C were 
designated as RK- mutants. RK- frequency on rich TB plates = Titer on TB at 42°C / Titer on TB 






3.3.2. Assessing if the inclusion of Casamino acids (not vitamin free) in MM agar 
suppresses the drop in RK- frequency  
 
 On addition of Casamino acids (not vitamin free) to minimal medium, the drop in cell 
titer at 42°C was suppressed which suggested that nutrient gene mutations might be present 
among the rare RK- survivors (Tables 3 and 4). 
  
Table 3. Efficiency of plating of RK+ culture cells on rich TB and MM+CA at 30°C 
(Control for Table 4) 
 
  
Strain Experiment # Titer on TB at 
30⁰C a 
Titer on MM+CA 
at 30⁰C a 
Titer on TB / 
Titer on 
MM+CA 
Mean ± Standard 
error 
1 6 x 108 5.5 x 108 b 1.09 Y836 his- 
2 1.5 x 109 1.6 x 109 c 0.94 
1.02 ± 0.075 d 
 
a
 Y836his- cells were plated on rich TB and MM+CA agar plates at 30°C and the cell titers on 
the above plates were determined. 
b
 Used 1% final concentration of Casamino acid (not vitamin free). 
c
 Used 0.3% final concentration of Casamino acid (not vitamin free). 
d
 Standard error has been calculated by taking 2 sets of data into consideration. 
 
 The difference between Table 2 and Table 4 is that in Table 2, the RK- frequency on MM 
is lower than that on TB plates at 42°C whereas in Table 4, the RK- frequency on TB is lower 
than that on MM+CA at 42°C which indicates that MM+CA recovers more RK- mutants than 
TB.     
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Table 4. The recovery of RK- mutants is enhanced on MM by the addition of CA 
   






  TB MM+CA   
1 6.33 x 10-6 1.24 x 10-5 b 0.51 
2 4.5 x 10-6 8.91 x 10-6 b 0.51 
Y836 his- 
3 3.87 x 10-6 5.13 x 10-6 c 0.75 
0.59 ± 0.08 
 
a
 Y836 his- cells were plated on rich TB and MM+CA agar plates at 42°C. RK- frequency on rich 
TB plates = Titer on TB at 42°C / Titer on TB at 30°C and RK- frequency on MM+CA plates = 
Titer on MM+CA at 42°C / Titer on MM+CA at 30°C. 
b
 Used 1% final concentration of Casamino acid (not vitamin free). 
c
 Used 0.3% final concentration of Casamino acid (not vitamin free). 
 
 
3.3.3. Important controls established by Chu (Chu, 2005) 
 
  Chu found that Y836 did not have intrinsic mutator activity. It was also ruled out that the 
drop in RK- frequency on MM relative to rich TB was linked to the bio operon (due to deletion 
in λ fragment). In other words, addition of biotin to minimal medium did not suppress the drop in 
RK- frequency. Also, the drop in RK- frequency and the appearance of auxotrophs among the 
RK- mutants was not linked to the SOS gene products (Chu, 2005). 
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 Chu showed that pcI+ plasmid expressing wild-type CI repressor at 30°C and 42°C 
completely suppressed replicative killing in Y836, Y836 his+, 594::(cIII-ren)λ and W3101::(cIII-
ren)λ cells (Chu, 2005). This suggested that the cell killing was linked to λ gene expression. 
Hayes et al. reported that grpD55 mutations (2 missense mutations) in host dnaB gene 
suppressed λ replication initiation from oriλ (Hayes et al., 2005). Moreover, grpD55 mutations 
completely suppressed replicative killing (or, RK phenotype) (Chu, 2005). But, grpD55 
mutations did not completely suppress the drop in RK- frequency on minimal media relative to 
rich media which suggested that “DNA lesions preventing colony formation at 42°C likely 
appear within the population of Y836dnaBgrpD55 cells induced for λ gene expression” (Chu, 
2005). In other words, Chu concluded that auxotroph formation was not linked to replicative 
killing or, auxotroph formation did not require actual replication initiation from oriλ (Chu, 2005). 
λ gene expression triggered auxotroph formation (Chu, 2005). Auxotrophy was a very broad 
target for mutagenesis. A small target, rifampicin resistance was also briefly studied by Chu and 
similar links to λ gene expression were found (Chu, 2005). Chu showed that auxotroph formation 
was linked to λ P gene expression from a cryptic λ prophage (Chu, 2005). Since some RK- 
strains used by Chu were not sequenced (for λ genes O and P) then, the assay of the strains had 
to be repeated and confirmed. Also, further work was necessary to ascertain whether the λ gene 
product P could influence the apparent mutator phenotype, which we define as ancillary 
mutations within E. coli chromosome that arise during selection at 42°C for RK- mutants.     
 
3.4.     Determining whether λ gene product(s) is/are responsible for triggering auxotrophic 
mutations  
 
   Chu linked formation of auxotrophs with λ P gene expression from a cryptic λ prophage 
(Chu, 2005). In this study, actual colony forming units (cfu) arising on rich TB plates were 
picked with sterile toothpicks and stabbed onto minimal media plates for auxotrophy 
confirmation. This is a better way of looking for auxotrophs as each individual colony can be 
analysed. Stab assays of Y836, 594::(cIII-ren)λ and Y836dnaBgrpD55 were done by Chu (Chu, 
2005) and we repeated these assays for these strains in Figure 9 and Supplemental Table 5 for 
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confirmation. The results were similar to those of Chu (Chu, 2005). GrpD55 mutations in dnaB 
gene suppressed auxotroph formation to some extent (Figure 9 and Supplemental Table 5).  
 In this study, four isolated and sequenced Replicative Killing defective (RK-) mutants, 
and one Y836 mutant with a kanamycin insertion in P (constructed by recombineering by S. 
Hayes) were employed. The RK- mutants, Y836 ilr O208b P+ and Y836 ilr O223a P+ have 
spontaneous mutations in O-origin site that prevent λ replication initiation. Y836 ilr O+P::IS2 
RK- mutant has a spontaneous IS2 insertion in P. Y836 ilr 534c O+P+ strain is RK- but 
sequenced as O+P+, suggesting that the mutation preventing λ replication initiation is in a 
chromosomal gene, possibly dnaA or in another λ gene. Since Y836 ilr 534c O+P+ strain 
complemented for P, i.e., λimm434Pam3 phage grew on this strain, it was inferred that in Y836 
ilr 534c O+P+ cells, all host genes required for λ replication were functioning properly. Upon 
shifting a Y836 strain with a kanamycin insertion in P (Y836 O+P::Kan) from 30°C to 42°C, no 
auxotrophs arose among the 42°C cfu. Moreover, the isolated and sequenced RK- mutants, Y836 
ilr O208b P+, Y836 ilr O223a P+ and Y836 ilr 534c O+P+ yielded auxotrophs at 42°C unlike the 
P- strain, Y836 ilr O+P::IS2 (Figure 9 and Supplemental Table 5). These results agreed with 



































































































Figure 9. Stab assay to look for auxotrophs among the 42°C cfu. Cfu that arose on rich tryptone 
agar plates at 42°C were picked with a sterile toothpick and stabbed to duplicate MM or MM+his 
plates incubated at 30°C and 42°C and a control rich TB agar plate incubated at 30°C. Colonies 
that were not able to grow on MM or MM+his agar plate at either 30°C or 42°C were 
auxotrophs. Chu (Chu, 2005) and this study identified some of the auxotrophs to be Ts 
conditional auxotrophs. [See actual data in Supplemental Table 5.] When shifted from 30°C to 
42°C, Y836 cells underwent 9x105-fold cell killing, Y836 O+P::Kan cells underwent 153-fold 
cell killing, Y836dnaBgrpD55 cells underwent 2668-fold cell killing, 594::(cIII-ren)λ cells 
underwent 105-fold cell killing, Y836 ilr O223a P+ cells underwent 4762-fold cell killing, 
594dnaBgrpD55 cells underwent 7-fold cell killing, 594 cells underwent 6-fold cell killing and 
no cell killing was observed in Y836 ilr O208b P+, Y836 ilr 534c O+P+ and Y836 ilr O+P::IS2 
cells on rich TB plates. 
 
Fold cell     9x105       153        2668 a        105              0              0          4762           0           7            6               
killing  




 In these assays, Y836dnaBgrpD55 cells underwent cell killing when shifted from 30°C to 42°C 
for some unknown reasons. Other assays done with the same strain (data shown in Figures 5 and 
10) did not undergo any cell killing when shifted from 30°C to 42°C which agreed with Chu’s 
findings (Chu, 2005). Also, 594dnaBgrpD55[pcIpR-P-timm] cells did not undergo cell killing 
when shifted from 25°C to 37°C (data shown in Figures 6 and 11) which proved that grpD55 
mutations in DnaB knocked out P-killing.  
 
3.5. Assessing whether the apparent mutator activity can be demonstrated using   
another target and whether host DnaB is required for the potential mutator activity   
  
 To assess whether the apparent mutator activity can be demonstrated by employing an 
independent selection (other than screening for auxotrophs), rifampicin resistance was employed 
as another possible target for potential mutator activity. Unlike auxotrophy, rifampicin resistance 
is a narrow target and is conferred by rpoB gene mutations. Chu showed that Y836 (O+P+) 
exhibited a high frequency of rifampicin resistance at 42°C when compared to 30°C (Chu, 2005). 
Chu also showed that grpD55 mutations in dnaB gene suppressed the increase in rifampicin 
resistance frequency (Chu, 2005). The same results were reproduced in this work for 
confirmation (Figure 10 and Supplemental Table 6). 
 As a part of this work, it was found that insertional inactivation of P in Y836 O+P::Kan 
cells suppressed rifampicin resistance frequency by approximately 105-folds at 42°C in 
comparison to Y836 P+ cells. Sequenced RK- mutant, Y836 ilr O223a P+ showed an 
approximately 2000-fold increase in rifampicin resistance frequency from 30°C to 42°C. In a 
comparison between Y836 ilr O223a P+ and Y836 ilr O+P::IS2 cells, the inactivation of P by an 
IS2 insertion resulted in an approximately 2000 fold drop in rifampicin resistance frequency at 
42°C (Figure 10 and Supplemental Table 6). It was inferred that the increase in the frequency of 




Figure 10. Induction assay of cells for determining rifampicin resistance frequency at 42°C 
vs. 30°C 
 























Figure 10. Induction assay of cells for determining rifampicin resistance frequency at 42°C vs. 
30°C. A volume of late-log to stationary phase cells were washed once and the cell pellet was 
resuspended in the same volume of Φ80 buffer. The diluted cells were plated on rich tryptone 
agar plates and tryptone agar plates supplemented with rifampicin at a final concentration of 
100µg/ml at 30°C and 42°C for 48 hours. The 42°C plates were prewarmed for ~2 hours. 
Frequency of rifampicin resistance at 30°C = Number of rifR cfu/ml on TB+Rif plates at 30°C / 
Number of cells (cfu/ml) on TB plates at 30°C. Frequency of rifampicin resistance at 42°C = 
Number of rifR cfu/ml on TB+Rif plates at 42°C / Number of cells (cfu/ml) on TB plates at 42°C. 
[See actual data in Supplemental Table 6.] When shifted from 30°C to 42°C, Y836 cells 
underwent 4x105-fold cell killing, Y836 O+P::Kan cells underwent 7-fold cell killing, 
Y836dnaBgrpD55 cells underwent 5-fold cell killing, Y836 ilr O223a P+ cells underwent 2x104-
fold cell killing and Y836 ilr O+P::IS2 cells underwent 3-fold cell killing on rich TB plates.    
 
Cell killing          +                        -                         -                         +                        -    





3.6.      Determining if P expression from a plasmid exhibits the potential mutator activity 
 
       It was asked whether P expression from a plasmid exhibited the potential mutator 
activity. This was a much more accurate way to pinpoint P and investigate whether P was the 
cause of the apparent mutator activity as the plasmid only expressed P under a cI[Ts] repressor.   
  A volume of each of the stationary phase cells of 594[pcIpR-P-timm] and 
594dnaBgrpD55[pcIpR-P-timm] were centrifuged and the cell pellets were resuspended in Φ80 
buffer. Serial dilutions of the cells were performed and were plated on TB+100µg/ml Rif and 
control TB plates at 25°C, 30°C and 37°C for 48 hours. It was found that 594[pcIpR-P-timm] 
showed an approximately 800-fold increase in rifampicin resistance frequency at 37°C (in 
comparison to 25°C) (Figure 11). This suggested that the increase in rifampicin resistance 
frequency is linked to λP expression. GrpD55 mutations in host dnaB gene suppressed rifampicin 
resistance frequency at 37°C by approximately 80-fold in comparison to wild-type 594[pcIpR-P-
timm] cells (Figure 11 and Supplemental Table 7) which suggested that P-DnaB interaction was 




















Figure 11. Induction assay of pcIpR-P-timm transformants of wild-type 594 and 
594dnaBgrpD55 cells for determining rifampicin resistance frequency at 25°C, 30°C and 
37°C 
 



























Figure 11. Induction assay of pcIpR-P-timm transformants of wild-type 594 and 594dnaBgrpD55 
cells for determining rifampicin resistance frequency at 25°C, 30°C and 37°C. A volume of 
stationary phase cells were washed once and the pellet was resuspended in the same volume of 
Φ80 buffer. (For 594[pcIpR-P-timm] cells, 5X concentrated cells were used and so, 5 ml cells 
were washed once and the cell pellet was resuspended in 1 ml of Φ80 buffer.) The diluted cells 
were plated on rich tryptone agar plates and tryptone agar plates supplemented with rifampicin at 
a final concentration of 100µg/ml at 25°C, 30°C and 37°C for 48 hours. The 37°C plates were 
prewarmed for ~2 hours. Frequency of rifampicin resistance at 25°C, 30°C or 37°C = Number of 
rifR cfu/ml on TB+Rif plates at indicated temperature / Number of cells (cfu/ml) on TB plates at 
the same indicated temperature, i.e., either 25°C, 30°C or 37°C. [See actual data in Supplemental 
Table 7.] When shifted from 25°C to 30°C, no cell killing was observed in 594[pcIpR-P-timm] 
and 594dnaBgrpD55[pcIpR-P-timm] cells on rich TB plates. When shifted from 25°C to 37°C, 
Cell killing                        -          +                                        -            - 
at 30°C 
& 37°C 
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594[pcIpR-P-timm] cells underwent 624-fold cell killing and no cell killing was observed in 
594dnaBgrpD55[pcIpR-P-timm] cells on rich TB plates. 
 
3.7.      Is P-DnaB interaction essential for the apparent mutator activity? 
 GrpD55 mutations are 2 missense mutations in host DnaB helicase protein. E. coli is able 
to use DnaBgrpD55 for its replication. But, phage λ does not grow on a grpD55 cell. Mutations 
in λ gene P allow the phage to grow on groP- mutants. These compensatory mutations in P are 
referred to as pi mutations (Georgopoulos and Herskowitz, 1971; Saito and Uchida, 1977; 
Georgopoulos, 1977; Sunshine et al., 1977) (Figure 12 and Supplemental Table 8). When wild-
type gene P was replaced by a deletion in P (∆P) or a pi mutation in P (Ppi) in a 594 or a 
594dnaBgrpD55 cell, the increase in rifampicin resistance frequency from 25°C to 37°C was 
greatly reduced. This suggested that P-DnaB interaction was necessary for the potential mutator 
activity observed.   
 
Figure 12. Induction assay of P, ∆P and Ppi-expression plasmid transformants of wild-type 
594 and 594dnaBgrpD55 cells for determining rifampicin resistance frequency at 25°C, 
30°C and 37°C  
 












































































































Fold cell killing       624                         0                          21                          3                         22 
at 37°C 
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Figure 12. Induction assay of P, ∆P and Ppi-expression plasmid transformants of wild-type 594 
and 594dnaBgrpD55 cells for determining rifampicin resistance frequency at 25°C, 30°C and 
37°C. A volume of late-log to stationary phase cells were washed once and the pellet was 
resuspended in Φ80 buffer. The diluted cells were plated on rich tryptone agar plates and 
tryptone agar plates supplemented with rifampicin at a final concentration of 100µg/ml at 25°C, 
30°C and 37°C for 48-72 hours. The 37°C plates were prewarmed for ~3½-4 hours. Fold 
changes in frequency of rifampicin resistance at 37°C w.r.t. 25°C = Frequency of rifR at 37°C / 
Frequency of rifR at 25°C. [See actual data in Supplemental Tables 8, 9 and 10.] When shifted 
from 25°C to 37°C, 594[pcIpR-P-timm] cells underwent 624-fold cell killing, 594[pcIpR-Ppi-
timm] cells underwent 21-fold cell killing, 594[pcIpR-∆P-timm] cells underwent 22-fold cell 
killing, 594dnaBgrpD55[pcIpR-Ppi-timm] cells underwent 3-fold cell killing and no cell killing 
was observed in 594dnaBgrpD55[pcIpR-P-timm] cells on rich TB plates. 
 
3.8.   Studying the variation in the appearance of rifR mutants in presence and absence of P 
expression via Low Dose Inoculum Assay (LDIA) 
 
   
 The data in Figure 11 suggests that the increase in rifampicin resistant frequency from 
25°C to 37°C in 594[pcIpR-P-timm] cells is linked to λP expression. Since 594[pcIpR-P-timm] 
cells were killed at 37°C, it was asked whether the appearance of rifampicin resistant mutants 
was stimulated by P or whether it was just an enrichment of pre-existing mutations. To test this, 
it had to be determined whether the actual number of rifR cfu that arose at 37°C was higher than 
those that arose at 25°C. We used Low Dose Inoculum Assay (LDIA) which involved the assay 
of many individual cultures prepared from a few cells. In order to study the variation in the 
appearance of rifampicin resistant mutants in presence of P, 15 cells of 594[pcIpR-P-timm] were 
added to each of 40 tubes containing 1 ml TB and all 40 inoculated cultures were grown at 25°C 
for 48 hours to stationary phase. 0.1 ml cell aliquots from the 40 individual tubes were plated on 
two rich TB agar supplemented with rifampicin at a final concentration of 100µg/ml. One plate 
was incubated at 25°C and the other at 37°C. With only 15 cells added per 1 ml of TB, the 
chance of 1 cell out of 15 being a rifR mutant is very low, about 1:10-100 million, as the 
spontaneous rifR frequency is to the order of 10-8 to 10-9. At 25°C (graph on top left of Figure 
13), no rifR cfu arose on TB+Rif selection plates when cells from culture # 8, 18, 19, 21, 22, 23, 
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28, 33 and 37 were plated. Whereas at 37°C (graph on top right of Figure 10), rifR cfu arose from 
the same cultures when plated on TB+Rif selection plates. This proved that the rifR cfu that grew 
on TB+Rif plates at 37°C were not present in the initial culture in the tubes. If the rifR mutants 
had arisen in the culture, they would have formed colonies on the TB+Rif selection plates at 
25°C which was not the case. The only difference between 25°C and 37°C is that there is P 
expression at 37°C unlike at 25°C. The same inference can be made from the data from culture # 
9, 10, 25 and 27 which showed a higher number of rifR mutants at 37°C when compared to 25°C. 
The above data suggested that the rifR mutants that arose at 37°C upon P expression were not 
pre-existing mutants. The mutations must have been generated during colony formation. 
However, in case of majority of the cell cultures (culture # 1-7, 11, 12-17, 20, 24, 26, 29, 30, 32, 
34-36, 38 and 40), the number of rifR cfu dropped at 37°C when compared to 25°C which 
questioned the idea that the increase in the number of rifampicin resistant mutants (i.e., the 



























Figure 13. Quantitation of rifR mutants via Low Dose Inoculum Assay (LDIA) approach 
(individual cultures exposed to P expression) 
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 A                                                              B 
Figure 13. Quantitation of rifR mutants via Low Dose Inoculum Assay (LDIA) approach 
(individual cultures exposed to P expression). 15 cells of 594[pcIpR-P-timm] were added to each 
of 40 tubes containing 1 ml rich TB and all 40 inoculated cultures were grown at 25°C for 48 
hours to stationary phase. 0.1 ml cell aliquots from each of the 40 tubes were plated on two rich 
TB plates supplemented with rifampicin at a final concentration of 100µg/ml. One plate was 
incubated at 25°C and the other was incubated at 37°C. The graphs show rifR cfu/ml selected at 
25°C (A) and 37°C (B). [See actual counts in Supplemental Tables 11 and 12.] It is to be noted 
that the control for Graph B is Graph A. There was an approximately 83-fold toxicity in 
594[pcIpR-P-timm] cells at 37°C in comparison to 25°C on rich TB plates.  
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3.9.    Isolation of independent rifampicin resistant mutants from Low Dose Inoculum 
Assay for sequence analysis 
  
          In order to study the rpoB gene of the rifR mutants, one rifR mutant was isolated from each 
tube of the Low Dose Inoculum Assay (Figure 13). 22 spontaneous rifampicin resistant mutants 
(that arose at 25°C) and 12 rifampicin resistant mutants that arose in the presence of P expression 
(at 37°C) were isolated (after confirmation for rifR on TB+100µg/ml Rif plates) from starting rifS 
594[pcIpR-P-timm] cells (Table 5). Also, 4 independent rifR mutants (that have never seen P) 
were isolated from wild-type 594 cells for control experiments. DNA sequence analysis (not 
shown) performed by S. Hayes and C. Hayes, showed that mutations in rpoB gene conferred 
rifampicin resistant phenotype to the mutants. Plasmid retention analysis of the isolated rpoB rifR 
mutants revealed that 21 out of 22 spontaneous rifR rpoB mutants (that arose at 25°C in the 
absence of P expression) retained the P-expression plasmid and 11 out of 12 rpoB rifR mutants 



























Table 5. RifR mutants isolated from rifS 594[pcIpR-P-timm] cells via Low Dose Inoculum 
Assay (LDIA) 
 
Spontaneous rifR mutants isolated at 25°C RifR mutants isolated at 37°C in the presence of P 
expression 
sc325A4 a – from culture #4 in Figure 9A sc337A10 b – from culture #10 in Figure 9B 
sc325A6 – from culture #6 in Figure 9A sc337B1 – from culture #11 in Figure 9B 
sc325A7 – from culture #7 in Figure 9A sc337B8 – from culture #11 in Figure 9B 
sc325A9 – from culture #9 in Figure 9A sc337C1 – from culture #21 in Figure 9B 
sc325A10 – from culture #10 in Figure 9A sc337C4 – from culture #24 in Figure 9B 
sc325B1 – from culture #11 in Figure 9A sc337C5 – from culture #25 in Figure 9B 
sc325B2 – from culture #12 in Figure 9A sc337C6 – from culture #26 in Figure 9B 
sc325B3 (P-expression plasmid was lost) –  
From culture #13 in Figure 9A  
sc337C7 (P-expression plasmid was retained) – from 
culture #27 in Figure 9B 
sc325B6 – from culture #16 in Figure 9A sc337D1 – from culture #31 in Figure 9B 
sc325B10 – from culture #20 in Figure 9A sc337D2 – from culture #32 in Figure 9B 
sc325C4 – from culture #24 in Figure 9A sc337D3 – from culture #33 in Figure 9B 
sc325C5 – from culture #25 in Figure 9A sc337D6 – from culture #36 in Figure 9B 
sc325C6 – from culture #26 in Figure 9A  
sc325C10 – from culture #30 in Figure 9A  
sc325D1 – from culture #31 in Figure 9A  
sc325D2 – from culture #32 in Figure 9A  
sc325D4 – from culture #34 in Figure 9A  
sc325D5 – from culture #35 in Figure 9A  
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sc325D6 – from culture #36 in Figure 9A  
sc325D8 – from culture #38 in Figure 9A  
sc325D9 – from culture #39 in Figure 9A  
sc325D10 – from culture #40 in Figure 9A  
 
a
 sc325A4 denotes that the rifR mutant arose from starting rifS 594[pcIpR-P-timm] sc 3 cells at 
25°C from tube/culture # A4. 
b
 sc337A10 denotes that the rifR mutant arose from starting rifS 594[pcIpR-P-timm] sc 3 cells at 
37°C from tube/culture # A10. 
 
Table 6. RifR mutants isolated from rifS 594 cells 
RifR mutants isolated at 25°C RifR mutants isolated at 37°C 
594sc125A2 – from another assay (data not shown) 594sc137A2 – from another assay (data not shown) 
594sc325E a – from culture #44 in Figure 9A 594sc337D b – from culture #43 in Figure 9B 
 
a
 594sc325E denotes that the rifR mutant arose from starting rifS 594 sc 3 cells at 25°C from 
tube/culture # E. 
b
 594sc337D denotes that the rifR mutant arose from starting rifS 594 sc 3 cells at 37°C from 






3.10.    Does rifampicin resistance confer cellular resistance to P-toxicity?  
 
             In the Low Dose Inoculum Assay (LDIA), the 37°C rifampicin resistant mutants 
survived P-toxicity. So, it was asked whether the rifR cfu that arose at 37°C in LDIA were 
resistant to P. To address this, the cured a or plasmid-less rifR mutants (isolated from rifS 
594[pcIpR-P-timm] cells at 37°C (column on the right of Table 5)) that survived the thermal 
induction of P expression during selection, were transformed with the pcIpR-P-timm plasmid 
and were selected on TB+50µg/ml Amp plates at 37°C and 25°C. To find out whether rifampicin 
resistance is linked to P-resistance, 4 rifR mutants (that have never seen P – Table 6), 
594sc125A2, 594sc137A2, 594sc325E and 594sc337D, isolated from wild-type 594 cells, were 
transformed with pcIpR-P-timm plasmid and were selected on TB+50µg/ml Amp plates at 37°C 
and 25°C. It was found that all the rifampicin resistant mutants transformed with the P-
expression plasmid exhibited some degree of resistance to P-toxicity. It is to be noted that the 
drop in transformation frequency of the rifampicin resistant mutants at 37°C (w.r.t. 25°C) were at 
least 10-fold lower than that of the 594 wild-type control strain. Moreover, many of the rifR 




 In the Low Dose Inoculum Assay (LDIA), one rifR colony was picked from each of the 37°C 
TB+Rif plates (which corresponded to an individual culture tube) that had rifR colonies on them. 
By examining the colonies, it was found that 11 out of 12 of the rifR mutants that arose at 37°C 
in the presence of P expression had lost the P-expression plasmid. So, these rifR cells had been 










Table 7. RifR mutants that survived the thermal induction of P expression during selection 
and 594 rifR mutants (that have never been exposed to P) are sensitive to P-toxicity     
 
Frequency of appearance 
of AmpR transformants at: 








~25°C c 37°C d 












bp in rpoB 
h
 
1 1.24 x 10-4 < 7.4 x 10-8 > 1680 g 
2 4.64 x 10-5 < 2 x 10-8 > 2320 
 
594 wt 




1 1.65 x 10-6 4.6 x 10-8 35.9 g sc337B8 a 
2 2.53 x 10-7 3.6 x 10-8 7.03 
21 ± 14 - 
1 2.28 x 10-6 < 1.2 x 10-8 > 190 g sc337D6 a 
2 1.98 x 10-6 5.45 x 10-7 3.63 
100 ± 90 f 1609 
1 9.81 x 10-7 < 1.2 x 10-8 > 81.8 g sc337C1 a 
2 2.32 x 10-6 < 1.4 x 10-8 > 166 
124 ± 42 f - 
1 4.53 x 10-6 1.7 x 10-8 266 g sc337C6 a 
2 1.68 x 10-5 4 x 10-7 42 




1 2.02 x 10-5 9.53 x 10-7 21.2 g sc337D2 a 
2 3.3 x 10-6 1.46 x 10-6 2.26 
12 ± 9 - 
1 2 x 10-6 2 x 10-8 100 g sc337C5 a 
2 1.05 x 10-6 < 9 x 10-9 > 117 
108 ± 8 f 1691 
1 7.44 x 10-6 2.3 x 10-8 323 g sc337A10 a 





1 1.25 x 10-6 < 9 x 10-9 > 139 g sc337D1 a 




594sc125A2 b 1 3.88 x 10-6 2 x 10-8 194 194 1535 
594sc137A2 b 1 2.41 x 10-6 < 8 x 10-9 > 301 301 f 1586 
594sc325E b 1 1.57 x 10-6 < 6 x 10-9 > 262 262 f 1592 
594sc337D b 1 2.67 x 10-6 1.7 x 10-8 157 157 1714 
 
a These rifampicin resistant mutants have been isolated at 37°C. During selection, these mutants 
lost the P-expression plasmid (Table 5 – coloumn on the right). 
b
 These rifampicin resistant mutants have been isolated from wild-type 594 cells in the absence 
of P (Table 6). 
c
 The P-expression plasmid, pcIpR-P-timm was transformed into sc337C5 rifR mutant cell and 
the transformants were selected on TB plates supplemented with ampicillin at a final 
concentration of 50µg/ml at ~25°C. Frequency of transformation at ~25°C = Transformant 
cfu/ml on TB+Amp plates at ~25°C / Cell titer (cfu/ml) on control TB plates at ~25°C. 
d
 The P-expression plasmid, pcIpR-P-timm was transformed into sc337C5 rifR mutant cell and 
the transformants were selected on TB plates supplemented with ampicillin at a final 
concentration of 50µg/ml at 37°C. Frequency of transformation at 37°C = Transformant cfu/ml 
on TB+Amp plates at 37°C / Cell titer (cfu/ml) on control TB plates at ~25°C. 
e
 Fold drop in transformation frequency at 37°C w.r.t. ~25°C = Frequency of transformation at 
37°C / Frequency of transformation at ~25°C.         
f
 Minimum value possible. 
g These assays were done with the same pcIpR-P-timm plasmid DNA preparation and hence, the 




 DNA sequencing done by S. Hayes and C. Hayes.  
Note: Other than 594 wt, 594sc125A2, 594sc137A2, 594sc325E and 594sc337D cells, standard 
error has been calculated by taking 2 sets of data into consideration. 
 
3.11. Phenotypic characterization of isolated rpoB rifampicin resistant mutants 
         In order to characterize the isolated rpoB rifR mutants, the different viability and plasmid 
retention phenotypes of the mutants upon P expression from the plasmid was studied. We asked 
whether any of the isolated rifampicin resistant mutants that retained the P-expression plasmid 
(25°C isolates and one 37°C isolate) were resistant to P-toxicity. To test this, the rifR mutants 
containing the P-expression plasmid were induced for P expression at 37°C. Upon P expression, 
the cell viability and plasmid retention phenotypes were assessed. It was found that a subset of 
rpoB selected rifR mutants were resistant to P. Some mutants were either resistant to P-lethality 
like sc325D6, sc325C5, sc337C7, sc325D10 and sc325B10 or resistant to plasmid loss like 
sc325C10, sc325D6, sc325D2, sc325B1, sc325C5, sc325D10, sc325B10, sc337C7, sc325C6, 
sc325D8, sc325A6, sc325D9 and sc325A9 (Table 8). This suggested that a subset of rpoB 
selected rifampicin resistant mutants confer resistance to P. 
         It was also asked whether the 594 rifR mutants that were isolated from wild-type 594 cells 
in the absence of P expression, were resistant to P. After transforming the 594 rifR mutants with 
the wild-type P-expression plasmid, the same assay as above was employed to study viability 
and plasmid retention upon P expression. 594sc137A2 and 594sc337D were found to have some 
degree of resistance to P (Table 8) which suggested that certain rpoB mutants can confer cellular 













Viability at 37°C w.r.t. 
25°C titer f 
(Mean ± Standard error) 
Plasmid retention 
among the 37°C 
survivors  
(no. of cfu that have 
the plasmid/total no. 








bp in rpoB i 
sc325C10 a <0.001 & 0.000007 26/26 100 1586 
sc325D1 a 0.0012 & 0.0008 
(0.001 ± 0.0002 h) 
3/25 12 1574 
sc325D6 a 0.1517 & 0.9048 
(0.53 ± 0.38 h) 
25/25 100 1601 
sc325A10 a <0.0007 & 0.2093 2/25 8 1592 
sc325D2 a <0.001 & 0.0368 23/25 92 1576 
sc325D5 a 0.0125 & 0.3881 
(0.20 ± 0.19 h) 
3/25 12 1527 
sc325A7 a 0.0087 & 0.1144 
(0.062 ± 0.053 h) 





0/28 & later, same 28 







sc325B1 a 0.0034 & 0.172 
(0.088 ± 0.084 h) 
21/27 77.78 1605-13 
sc325C5 a 1.0803 20/26 76.92 1691 
sc325B6 a 0.0024 & 0.0303 
(0.0164 ± 0.014 h) 
16/28 57.14 No data 
sc337C7 b 1.0336 & 0.9753 
(1.005 ± 0.029 h) 
26/26 & 65/65 100 1601 
sc325C6 a 1.0476; 0.1964 & 0.0385 26/26 & 3/22 100 & 13.64 1592 
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a These rifampicin resistant mutants have been isolated at 25°C. These mutants retained the P-
expression plasmid (Table 5 – coloumn on the left). 
(0.43 ± 0.31) (57 ± 43) 
sc325B10 a 0.8155 28/28 100 1600 
sc325D10 a 1.1039 & 0.9389 
(1.021 ± 0.083 h) 
45/45 & 40/40 100 1604-12 
sc325D4 a 0.0196 4/26 15.38 No data 
sc325D8 a 0.0665 27/30 90 1691 
sc325A6 a 0.1222 29/29; 25/25 & 38/38 100 1595 
sc325D9 a 0.025 29/29; 28/28 & 36/36  100 1565 
sc325A9 a 0.0261 32/46  69.57 1687 
sc325C4 a 0.1639 0/36 0 1687 
sc325A4 a < 0.00096 No data - 1585 
594sc125A2 c 0.0000164 &  
< 4 x 10-9 
15/22 68.18 1535 
594sc137A2 c 0.5586 &  
4.8 x 10-4 
(0.28 ± 0.28 h) 
23/26 88.46 1586 
594sc325E c 0.0898 & 0.0023 
(0.046 ± 0.044 h) 
0/28 & 0/4 0 1592 
594sc337D c 0.6115 & 0.029 
(0.32 ± 0.29 h) 
20/25 & 0/89 80 & 0 
(40 ± 40) 
1714 
sc337D6 d 0.027 95/102 93.14 1609 
Control rpoB+ 
594[pcIpR-P-timm] 
0.0043 ± 0.0016 0/30 0  
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b This rifampicin resistant mutant arose at 37°C in the presence of P expression. But, this is the 
only 37°C isolated mutant that retained the P-expression plasmid. This mutant complemented for 
P at 37°C which suggests that the P gene in the plasmid was wild-type. 
c
 These rifampicin resistant mutants have been isolated from wild-type 594 cells in the absence 
of P expression (Table 6). 
d This rifampicin resistant mutant arose at 37°C in presence of P. The P-expression plasmid was 
lost from this mutant strain during selection. 
e
 Except sc325D4 (P complementation assay not done), all the rifR mutants (that       contain a P-
expression plasmid, pcIpR-P-timm) complemented for P at 37°C. [See data in Supplemental 
Table 1.] 
f
 RifR mutant cells containing the P-expression plasmid, pcIpR-P-timm were diluted and plated 
on two rich TB agar plates that were incubated at 25°C and 37°C. Viability at 37°C w.r.t. 25°C 
titer = Titer on TB at 37°C / Titer on TB at 25°C.  
g
 RifR mutant cells containing the P-expression plasmid, pcIpR-P-timm were diluted and plated 
on two rich TB agar plates that were incubated at 25°C and 37°C. Survivor cfu at 37°C were 
picked with a sterile toothpick and stabbed onto a TB plate supplemented with ampicillin at a 
final concentration of 50µg/ml and a control TB plate. Ability of a cfu to grow on TB+Amp plate 
suggests that the cfu has the plasmid in it. 
h
 Standard error has been calculated by taking 2 sets of data into consideration. 
i
 DNA sequencing done by S. Hayes and C. Hayes. 








3.12.  Determining if a 9 base pair deletion in host rpoB gene that affected 4 amino                     
acids confers cellular resistance to P-toxicity 
   
 S. Hayes and C. Hayes determined by DNA sequence analysis that sc325D10 had a 9 bp 
deletion in rpoB that affected 4 amino acids. The spontaneous rifR mutant, sc325D10 was 
isolated at 25°C (in the absence of P expression) from the Low Dose Inoculum Assay (LDIA) 
and it retained the P-expression plasmid. Upon thermal induction of P expression at 37°C, 
sc325D10 was found to be resistant to P-lethality and the 37°C cfu were found to retain the P-
expression plasmid (Table 8). As sc325D10 mutant was found to be completely resistant to P, it 
was asked whether the 9 bp deletion in rpoB that affected 4 amino acids was responsible for P-
resistance. To test this, the sc325D10 rpoB DNA (actual sequenced PCR product) containing the 
deletion was electroporated into 594[pSIM6] cells containing the λ Red recombination system. 
RifR recombinants were selected on TB+100µg/ml Rif plates at 30°C. Sequencing of the 
recombinants revealed that the 9 bp deletion (that affected 4 amino acids) successfully 
recombined with the wild-type rpoB DNA. The P-expression plasmid was transformed into the 
resulting recombinant, 594rpoB-(D10). Upon thermal induction of P expression in the resulting 
transformant (594rpoB-(D10)[pcIpR-P-timm]), it was found that 594rpoB-(D10) was sensitive to 
P which suggested that the deletion in rpoB alone did not contribute to P-resistance in the parent 










Table 9. 9 base pair deletion in rpoB that affected 4 amino acids does not confer cellular 




 sc325D10 rifR mutant (that retained the P-expression plasmid) was isolated at 25°C (in the 
absence of P) from rifS 594[pcIpR-P-timm] cells. sc325D10 mutant was resistant to P-killing at 
37°C and the 37°C cfu retained the P-expression plasmid. DNA sequencing of sc325D10 
revealed that the isolated rifR mutant had a 9 bp deletion in rpoB (S. Hayes and C. Hayes) that 
affected 4 amino acids. To find out whether the rpoB deletion was responsible for the P-resistant 
phenotype, the PCR fragment sequenced was electroporated into a wild-type 594[pSIM6] cell. 
pSIM6 plasmid contains λ Red recombination genes that will allow the electroporated fragment 
to recombine with the wild-type recipient chromosome. RifR recombinants were selected at 30°C 
on rich TB plates supplemented with rifampicin at a final concentration of 100µg/ml. After rifR 
confirmation, the 594rpoB-(D10) or Tsc325D10 recombinants were transformed with the pcIpR-
P-timm plasmid. The transformants were selected at ~25°C on rich TB plates supplemented with 
ampicillin at a final concentration of 50µg/ml. Then, these resulting transformants were induced 








~25°C titer c 
 
Plasmid retention 
among the 37°C 
survivors  
(no. of cfu that have 
the plasmid/total no. 






















0.0017)    
8/121; 2/50 and 0/20  6.61; 4 and 0 




 Cells were very slow growing. They took ~4 days to reach mid-log phase.   
c
 RifR mutant cells containing the P-expression plasmid, pcIpR-P-timm were diluted and plated 
on two rich TB agar plates that were incubated at 25°C and 37°C. Viability at 37°C w.r.t. ~25°C 
titer = Titer on TB at 37°C / Titer on TB at ~25°C. 
d
 RifR mutant cells containing the P-expression plasmid, pcIpR-P-timm were diluted and plated 
on two rich TB agar plates that were incubated at ~25°C and 37°C. Survivor cfu at 37°C were 
picked with a sterile toothpick and stabbed onto a TB plate supplemented with ampicillin at a 
final concentration of 50µg/ml and a control TB plate. Ability of a cfu to grow on TB+Amp plate 


















4.1.   λP-lethality 
 E. coli replication licensing factor, DnaC (Stillman, 1994) is known to bind DnaB 
helicase (Wickner and Hurwitz, 1975) and targets it to the bacterial origin of replication, oriC. 
Bacteriophage λ gene product P (λ replication licensing factor) outcompetes host DnaC protein 
for binding to host DnaB helicase (Mallory et al., 1990; Konieczny and Marszalek, 1995) and 
directs it to λ origin of replication, oriλ. The sequestration of host DnaB helicase by P deprives 
host DnaC protein the opportunity to bind DnaB and direct it to oriC. This is probably the 
simplest explanation of why host cell viability is lowered upon P expression. Section 3.1 shows 
that λP is lethal to host cells which agrees with the concept of ‘P-lethality’ established by 
Klinkert and Klein (Klinkert and Klein, 1979). Low levels of P protein do not kill the host cells 
but elevated levels of P are lethal (Maiti et al., 1991b). The re-repression (of P) assay in Section 
3.2 suggested that host cell viability is significantly lowered upon P expression. Prolonged 
cellular exposure to P kills the cells. One explanation for the reduced cell viability upon P 
expression can be the effect of P on cell replication.  
 A class of dnaB mutations called groP prevented wild-type phage λ growth at permissive 
temperatures for bacterial DNA synthesis, but allowed the growth of phage λ that possessed pi 
mutation in gene P (Dari et al., 1975). Georgopoulos and Herskowitz mapped groP mutations in 
the host dnaB gene (Georgopoulos and Herskowitz, 1971). Maiti et al. reported that although 
dnaBgroP mutants do not allow λ DNA replication, they remain susceptible to P-lethality (Maiti 
et al., 1991b). They inferred that wild-type DnaB was not required for P-lethality. However, 
Hayes (Hayes, 1979) proved that DnaB was required for λ replication initiation. Later, Hayes et 
al. showed that grpD55 allele of dnaB blocked λ replication initiation which suggested that P 
needs wild-type DnaB to initiate replication from oriλ (Hayes et al., 2005). Bull mapped the 
grpD55 mutations to the dnaB gene (Bull, 1995; Bull and Hayes, 1996). Later, the grpD55 
mutations were sequenced by Horbay (Horbay, 2005). Bull suggested that the grpD55 mutations 
in dnaB (that do not allow wild-type phage λ growth) might suppress P-lethality (Bull, 1995) 
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which was confirmed in Section 3.1 of this work. This proved that P-DnaB interaction was 
essential for P-lethality which refuted Maiti et al.’s findings (Maiti et al., 1991b) stated above. 
 
4.2.   ColE1 Plasmid Loss among P-survivors 
 Section 3.9 showed that 11 out of 12 of the rifR mutants that were isolated at 37°C upon P 
expression (from Low Dose Inoculum Assay) had lost the P-expression plasmid. Section 3.2 
showed similar results related to plasmid loss upon P exposure. My data suggests that the 
majority of the cells that survive P-lethality lose the P-expression ColE1 plasmid. It also shows 
that the cells that lose the P-expression plasmid survive. In our laboratory, experiments have 
been done by other researchers to isolate plasmid DNA from P-exposed 594[pcIpR-P-timm] 
cultures at 37°C and control 594[pcIpR-P-timm] cells at 25°C (when there is no P expression). 
pUC19 plasmid was used as a control for agarose gel analysis. Conclusions from gel data from 
the above experiments were similar to those from my stab assays. This supports the idea that P 
probably interferes with ColE1 plasmid replication. Unpublished data from our laboratory 
showed that plasmid loss does not occur upon P expression in a DnaBgrpD55 host. This suggests 
that since P cannot interact with the grpD55 conformation of DnaB helicase, ColE1 replication is 
not inhibited. In ColE1 plasmid replication, RNaseH cleaves the RNA-DNA hybrid to form 
primers. DnaB is reported to promote replication fork advancement in vivo (Lebowitz and 
McMacken, 1986; McMacken et al., 1977). For the ColE1 replication fork to advance, DnaB is 
required to unwind the DNA double strand. If P is interacting with DnaB during this step or if P 
is sequestering DnaB and making DnaB unavailable for this step, ColE1 replication will be 
inhibited. ColE1 plasmids do not have a partitioning system. So, there is unequal distribution of 
plasmid copies among daughter cells. If P inhibits ColE1 replication, plasmid copy number 
decreases. This increases the chances for plasmid loss. Also, PriA is known to restart stalled 
replication forks by loading DnaB helicase and is required for DnaB loading on the ColE1 
plasmid. So, if P is interacting with DnaB or sequestering DnaB, PriA may not be able to restart 
replication forks, and may be inhibited for ColE1 replication (Minden and Marians, 1985; Lee 




4.3.  DNA replication and causes of mutation 
 DNA polymerase enzymes are very particular about their choice of nucleotides during 
DNA synthesis. They ensure that the bases added to a growing strand are correctly paired with 
their complements on the template strand (i.e., A's with T's, and C's with G's). But, they also 
make mistakes at a rate of about 1 per 100,000 nucleotides. Cells have highly sophisticated ways 
of fixing most, but not all, mistakes made by DNA polymerases. Proofreading is a process which 
corrects most of the errors immediately during replication. Some errors are corrected after 
replication by a process called mismatch repair. During proofreading, DNA polymerases 
recognize the error and replace the wrongly inserted nucleotide, thus, allowing replication to 
continue. Proofreading fixes about 99% of these types of errors. But, this is still not good enough 
for cell functioning. After replication, the final error rate is further reduced by mismatch repair 
where enzymes recognize and fix the deformities, caused by the incorrectly paired nucleotides in 
the secondary structure of the final DNA molecule, by replacing the incorrectly paired nucleotide 
with the correct one. Incorrectly paired nucleotides that persist even after mismatch repair, 
become permanent mutations after the next cell division. This is because once the mistakes are 
established; the cell no longer recognizes them as errors. The DNA strand with established 
mistakes, serve as the template strand for future replication events causing all base pairings 
thereafter to be wrong (Pray, 2008). 
 Mutations can also be caused by various environmentally induced and spontaneous 
changes to DNA that occur prior to replication but are perpetuated in the same way as unfixed 
replication errors. As with replication errors, most environmentally induced DNA damage is 
repaired, resulting in fewer than 1 out of every 1,000 chemically induced lesions actually 
becoming permanent mutations. The same is true of so-called spontaneous mutations. 
"Spontaneous" refers to the fact that the changes occur in the absence of chemical, radiation, or 
other environmental damage. Rather, they are usually caused by normal chemical reactions that 
go on in cells, such as hydrolysis. Most of these spontaneous errors are repaired by DNA repair 
processes. But, if they are not repaired, a nucleotide that is added to the newly synthesized strand 
can become a permanent mutation (Pray, 2008). 
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 In this work, we studied λ gene product P which is a toxic agent. E. coli cells are killed 
upon P expression (Section 3.1). My data suggests that the mutator phenotype observed among 
the P-survivor cells is linked to P expression (Sections 3.4, 3.5, 3.6, 3.7 and 3.8). One possibility 
is that P is stimulating the mutations in the host chromosome by interacting with DnaB helicase 
during the replication propagation step, thus, perturbing replication fidelity. If this is true, P will 
be a toxic and a mutagenic agent. Upon P expression, most of the E. coli cells will be killed. 
Among the P-survivors, some will have a genome that has not been damaged (no lesions) and 
some will have DNA lesions (in this case, a mismatch) in their chromosome. If this mismatch is 
repaired, it will restore the pristine DNA sequence. Otherwise, the next round of replication will 
convert the mismatch into a permanent mutation (base alteration).                   
 
4.4. Assessment of the apparent mutator phenotype by Low Dose Inoculum Assay (LDIA) 
  
 In Luria-Delbrück Fluctuation Test, bacteriophage T1 was used as the selective agent 
(Luria and Delbrück, 1943). In the Low Dose Inoculum Assay (LDIA) used in this work, λP is 
the selective agent which means that any cell that has a pre-existing mutation (that make the cell 
resistant to P) in any of the genes with which P interacts (like dnaB or dnaA), will be resistant to 
P-toxicity. The other possibility is that the cells are killed or mutated upon expression of P, the 
selective agent. Our initial hypothesis was that P expression causes random mutations in the host 
E. coli chromosome. I tested this hypothesis by selecting for rifampicin resistant mutants from 
each of the LDIA parallel cultures at 25°C (not P-induced) and 37°C (P-induced) as shown in 
Section 3.8. I obtained more rifR mutants at 37°C than 25°C for some of the cultures, but not 
others. This was initially interpreted to suggest P-expression induced rifR mutants to arise after 
induction of P at 37°C. However, for this to be proven true, a number of controls need to be 
considered. For example, rifampicin antibiotic is known to stop transcription by inhibiting RNA 
polymerase. How rapidly does rifampicin inhibit RNA polymerase? We show that for some 
culture tubes in the Low Dose Inoculum Assay, rifampicin resistant mutants arose on the plates 
in the presence of P. We also argue that these mutants are not pre-existing mutants as they did 
not show up on the plates at 25°C when there was no P, and thus appear to support the 
hypothesis that P induction increases the frequency of rifampicin resistance.  
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 However, a number of additional factors need to be taken into consideration before 
accepting this finding as proof that P expression is increasing the mutation frequency. For 
example, is it even possible that the cells plated on TB+100µg/ml Rif plates would have 
sufficient time to induce P (or, transcribe P), allow P to interact with some unknown protein and 
cause mutations in the host DNA, allow mutant DNA to be transcribed with the rifampicin-
sensitive RNA polymerase to express the rifampicin resistant version that then accumulates to 
allow the cell to grow in the presence of rifampicin? This calls into question the idea that "when 
wild-type cells are exposed to P at 37°C on TB+100µg/ml Rif plates, P stimulates chromosomal 
mutations that confer rifampicin resistance phenotype to the cells".   
 It has been reported that the minimum inhibitory concentrations (MICs) of rifampicin for 
gram-negative bacteria are much higher (8-32 µg/ml) than those of gram-positive bacteria such 
as staphylococci (0.01 µg/ml). Hence, in gram-negative bacteria (in our case, E. coli), penetration 
of rifampicin through the outer membrane is the rate-limiting step and any kind of reduction in 
the outer membrane permeability may result in mutants with a significant degree of resistance to 
the antibiotic (Wehrli, 1983). But, in my experiments, 100 µg/ml rifampicin was used which is 
much higher than the highest MIC value for gram-negative bacteria reported by Wehrli.  
 Hayes (Hayes, 1979) compared lambda transcription from induced rifampicin sensitive 
and rifampicin resistant lysogenic cultures. For a rifS W3350(λcI857) cell, RNA synthesis from 
both the lambda and host DNA was reduced by 59- and 7-fold, respectively, by either 15.5- or 
1.5-min pretreatment with 200 µg/ml of rifampicin (Hayes, 1979). Therefore, transcription from 
the pR promoter is probably not completely shut off, though significantly reduced, which might 
result in the transcription of gene P and eventual synthesis of the P protein. The residual 
expression of P may be sufficient to generate a “P-induced” mutator effect, if any. 
 Rifampicin resistance used in this work is not an ideal target to determine whether P is 
stimulating rifampicin resistant mutations in the host chromosome by altering the E. coli rpoB 
gene. This is because some rifR mutants were found to be resistant to P-toxicity (Sections 3.10 
and 3.11) and thus, selection for rifR mutants in presence of P expression could be a result of 
enrichment for pre-existing mutants. Also, selecting for rifampicin resistant mutants upon P 
expression involves a double selection – seletion of P-resistant colonies and seletion of rifR 
colonies, i.e., upon thermal induction of P expression from 594[pcIpR-P-timm] cells at 37°C, the 
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rifR colonies that arise on TB+100µg/ml Rif plates at 37°C have to first survive P-lethality. It has 
been reported that stationary phase or adaptive mutations occur more often when selected than 
when not (Wright et al., 1999). So, double seletion might result in the increase in the rate of 
occurrence of mutations. Therefore, screening is a better way to look for mutations than 
selection. It is always a better way to screen, i.e., to do a survey among the P-survivors to look 
for possible mutants than to select for a mutation as this forces the mutation to arise. Hence, 
screening for auxotrophs among P-survivors was a good assay to determine whether P is 
involved in stimulating the nutrient gene mutations among the P-survivors. An important control 
that could have been done was to test whether the auxotrophic mutants were resistant to P-
toxicity. This could have been done by transforming the wild-type P-expression plasmid into few 
of the isolated auxotrophs and thermally inducing the plasmid for P expression and looking for 
P-killing. Screening for Mal- and Xyl- fermentation-defective mutants among P-survivors should 
have been used to show whether P was responsible for triggering the mutator phenotype in the 
host. A P- strain will serve as a control. Bull et al. used these targets for their study of 
hypermutation in chromosomal genes in association with adaptive Lac+ mutation (Bull et al., 
2000). Screening for auxotrophs or nutrient gene mutations, Mal- and Xyl- fermentation-
defective mutants are better assays for studying mutagenesis as these genes are silent during 
cellular growth phase on a rich medium at permissive temperatures.             
 The E. coli rpoB gene is a relatively small target and mutations in the rpoB gene 
represent a very small “window”. In other words, only a select few base changes might be 
allowed which may result in certain amino acid changes in RNA polymerase. Too many 
mutations in rpoB will probably have a lethal effect on the cell as the mutated RNA polymerase 
might not be able to function at all, thus shutting down transcription. I have reported the 
appearance of a very high number of rifampicin resistant mutants upon P expression at 37°C for 
some cultures (in Low Dose Inoculum Assay) and my data for those cultures suggest that P 
might be causing it as no mutants arose at 25°C for those cultures. If P is stimulating the mutator 
phenotype, i.e., if the appearance of high numbers of rifampicin resistant mutants at 37°C are 
triggered by P, it could be expected that there should be other mutations accumulating in the 
essential host genes too. During a burst of “P-induced” mutagenesis, how high must the level of 
mutations in other essential genes in the host chromosome be to support the very high number of 
rifampicin resistant mutants seen in Cultures 22 and 23 in Figure 13B. This is analogous to 
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‘Error Catastrophe’ (Crotty et al., 2001). A burst of random P-induced mutations in the host 
chromosome should decrease the chances of cell survival, thus decreasing mutant yield. While 
some of my data in Figure 13B show elevated rifR mutants to arise upon P induction, there are 
multiple cultures which did not yield increased rifampicin resistant mutants following P 
induction. It is difficult to envisage a P-dependent mutator mechanism that appears to be “hit or 
miss”. 
           
4.5.  Rifampicin resistance and P-resistance 
            One possible explanation for the observed apparent high rifR mutation rate among P 
expression surviving colonies could be that pre-existing rifR mutations somehow make the cell 
less sensitive to P-induced killing. If this were the case, selection for survivor of P induction 
would result in an enrichment of rifR colony forming units among the survivors and generate an 
apparent increase in rifR cfu among P-expression survivors. 
 To determine whether the plasmid-less or cured rifampicin resistant mutants that survived 
the thermal induction of P expression at 37°C, and 594 rifampicin resistant mutants (that were 
never exposed to P expression) were resistant to P-toxicity, a transformation assay was 
performed where the wild-type P-expression plasmid was transformed and ampicillin resistant 
transformants were selected at 25°C and 37°C on TB+Amp plates. My results (Section 3.10) 
show that the wild-type 594 control cells did not yield any P-expression plasmid transformants at 
37°C; whereas 2 out of 4 594 rifR mutants showed some transformants at 37°C suggesting that 
the presence of rifR mutations in rpoB can influence susceptibility to P expression. In support of 
this finding, almost all (6 out of 8) of the rifR mutants obtained from P-induced cultures were 
able to be transformed with the P-expression plasmid at 37°C. Significantly, many of these 
mutants were transformed at relatively high efficiency at 37°C in comparison to 25°C. Moreover, 
it has to be noted that the transformation frequency at 25°C for all of the rifR mutants was 
significantly lower than that of wild-type 594 cells possibly due to the altered RNA polymerase. 
The possibility that the altered RNA polymerase is interfering with the efficiency of ColE1 
replication of the transformed plasmid remains to be tested and if true, would also explain the 
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observed enrichment for rifR mutants among 37°C survivors of P expression, as any increase in 
the rate of plasmid loss will increase the number of apparent surviving cells.  
 
 In Section 3.8, an induction assay was performed by thermally inducing P from the P-
expression plasmid that was retained in the 25°C isolated rifR mutants obtained from Low Dose 
Inoculum Assay. For one 37°C rifR mutant which lost the P-expression plasmid (sc337D6) and 
for the 594 rifR mutants, the wild-type P-expression plasmid was transformed into the cells. My 
data (Table 8) indicated that many of the rifampicin resistant mutants (that arose at 25°C from 
LDIA) and 2 of the 4 rifampicin resistant mutants (that have never been exposed to P) that were 
isolated from wild-type 594 cells were resistant to P-toxicity. The only difference between 
Tables 7 and 8 was that Table 7 is a transformation assay and Table 8 is an induction assay.       
  
 A few control experiments can be done to help establish whether rifampicin resistant 
mutants are resistant to P-toxicity. For example, a wild-type pBR322 plasmid without P can be 
transformed into a wild-type 594 cell and a 594 rifR cell and the relative frequencies of 
appearance of transformants from 25°C to 37°C for both transformant strains can be determined. 
This would have determined whether rifampicin resistance influences the fidelity of plasmid 
maintenance. In essence, further experiments are needed to test this possibility.  
 
4.6.   Debate about λP and RNA polymerase interaction 
 There are no reports describing a physical interaction between λP and host RNA 
polymerase in the literature. However, McKinney and Wechsler demonstrated a genetic 
interaction between λP and host RNA polymerase in that specific combinations of λPpi mutants 
and rpoB rifR mutants increased or decreased λ’s plaque forming ability in an allele specific 
manner (McKinney and Wechsler, 1983) suggesting that λP, host DnaB helicase and RNA 
polymerase form a functional complex that is required for λ replication. The λ replication 
initiation protein P is known to interact with lambda O protein (Tomizawa, 1971) that binds to 
oriλ sites (Tsurimoto and Matsubara, 1981), and with host proteins DnaB (Georgopoulos and 
Herskowitz, 1971; Saito and Uchida, 1977; Klein et al., 1980) required as a helicase for 
chromosomal replication, and with heat shock proteins DnaJ (Yochem et al., 1978), DnaK 
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(Yochem et al., 1978), GrpE (Zylicz et al., 1987), and with DnaA (Wegrzyn et al., 1996; Datta et 
al., 2005b; Datta et al., 2005a), required for E. coli replication initiation, and possibly with RNA 
polymerase (McKinney and Wechsler, 1983). In λ replication initiation, P brings DnaB to an O-
oriλ complex to form the preprimosomal oriλ-O-P-DnaB complex (Dodson et al., 1989) involved 
in the θ mode of λ bidirectional replication initiation. The C-terminal region of λO contains a P-
binding domain (Furth et al., 1977; Furth and Yates, 1978; Wickner and Zahn, 1986). Recently, 
Szambowska et al. published an article showing that λO protein physically interacts with host 
RNA polymerase (Szambowska et al., 2011). Therefore, it will be of no surprise if P is found to 
be a part of such a complex. 
 My data do not show any evidence of a direct physical interaction between λP and E. coli 
RNA polymerase. However, the fact that a lot of the isolated rifampicin resistant mutants are 
resistant to P-toxicity suggest that P and RNA polymerase might be interacting with each other. 
It is known that the E. coli rpoB gene encodes the β-subunit of RNA polymerase. Mutations in 
rpoB confer rifampicin resistance to the cells. I found that a 9 base pair deletion in rpoB that 
affected 4 amino acids did not make the cell resistant to P. Hence, I do not have any data 
showing that P interacts with RNA polymerase. Further studies are required to resolve this 
debate. 
 
4.7. Future Experiments 
 Our introductory hypothesis was that λP expression stimulates random mutations in the 
host E. coli chromosome. We tested this hypothesis my using auxotrophy (mutation(s) in nutrient 
gene) and rifampicin resistance (mutation(s) in rpoB gene) as chromosomal targets. As some of 
the rifampicin resistant mutants showed some degree of resistance to P-toxicity, the observed 
apparent increase in the rifR frequency can be explained as an enrichment of pre-existing rpoB 
mutations. Hence, rifampicin resistance is not a good target for investigating whether P 
stimulates random mutations in the host chromosome. Similarly, it is important to find out 
whether auxotrophic mutations were making the host cells resistant to P-toxicity. To test this, a 
P-defective RK- auxotroph containing the cI immunity region, can be transformed with a P-
expression plasmid with a 434 immunity region. A P-expression plasmid with a cI immunity 
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region (pcIpR-P-timm) can be used to transform λ- RK- auxotrophs and auxotrophs obtained 
among the plasmid-cured P survivors (obtained upon thermal induction of P expression in 
594[pcIpR-P-timm] cells) and the resulting transformants should be thermally induced for P 
expression. Then, it has to be seen whether these cells survive P-toxicity. 
 Upon thermal induction of P-expression from the ColE1 plasmid in 594[pcIpR-P-timm] 
cells, the P-survivors were found to be cured of the plasmid. One hypothesis is that P is 
stimulating ColE1 plasmid loss from host cells. Another explanation is that the cells which lose 
the plasmid survive. This is a more probable explanation as the toxic agent, P is expressed from 
the plasmid itself which when lost, allows the cell to grow without inhibition. To test whether P 
stimulates ColE1 plasmid loss, a chromosomal P-expression system should be used instead of a 
plasmid P-expression system. P should be expressed from a prophage in a cell containing a 
pBR322 plasmid and then, plasmid loss should be studied among the P-survivors. 
 My data in Section 3.10 shows that the rifampicin resistant mutants were resistant to P-
toxicity. A few additional control experiments are needed to confirm this observation. A wild-
type pBR322 plasmid without P can be transformed into a wild-type 594 cell and into a 594 rifR 
cell and the relative frequencies of appearance of transformants from 25°C to 37°C for both 
transformant strains can be determined. These important controls will substantiate the data in 
Table 7. Since some rifR mutants are resistant to P-toxicity, it indicates that P might be 
interacting with RNA polymerase. Assays have to done to show whether λP and E. coli RNA 
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APPENDED SUPPORTING CONTROL EXPERIMENT: 
 
 P complementation assay was employed to study P expression from assay cells as a 
control experiment. A P amber mutant phage grew on host cells which expressed P at a 
particular temperature. The P amber mutant phage also grew on a suppressor TC600 bacterial 
strain a (control).        
a
 Nonsense suppressor strain: A bacterial strain / cell which has a mutation within the anticodon 
of a normal tRNA, enabling the mutated tRNA to recognize and insert an amino acid at a stop 
codon. 
  
Supplemental Table 1. P complementation assay using λimm434Pam3 phage 
 
Host strain Temperature 
(°C) 
Experiment # % Efficiency of 
plating a 
Mean ± Standard 
error 
1 58.18 39 
2 70.93 
64.6 ± 6.4 b Y836 





41 ± 12 Y836 ilr 534c O+P+ 
30 1 0.0178 0.0178 
1 56.92 
2 100.91 
Y836 ilr O208b P+ 39 
3 41.67 
67 ± 18 
 97 
1 0.0044 30 
2 0.0095 
0.0070 ± 0.0026 b 
1 33.08 39 
2 35.83 
34.5 ± 1.4 b Y836 ilr O223a P+ 





0.00022 ± 7.54 x 10-5 Y836 ilr O+P::IS2 





93 ± 24 c 
30 1 82.35 82.35 
594[pcIpR-P-timm] 
25 1 0.0762 0.0762 b 
1 < 0.000024 594[pcIpR-∆P-timm] 37 
2 < 0.000024 
< 0.000024 
sc325A6 37 1 157.69 157.69 
sc325A7 37 1 103.53 103.53 
sc325A9 37 1 126.92 126.92 
sc325A10 37 1 80 80 
sc325B1 37 1 98.82 98.82 
sc325B2 37 1 130.6 130.6 
sc325B6 37 1 87.06 87.06 
 98 
sc325B10 37 1 97.01 97.01 
sc325C4 37 1 165.38 165.38 
sc325C5 37 1 85.82 85.82 
sc325C6 37 1 138.06 138.06 
sc337C7 37 1 126.87 126.87 
sc325C10 37 1 35.29 35.29 
sc325D1 37 1 84.71 84.71 
sc325D2 37 1 82.35 82.35 
sc325D5 37 1 98.82 98.82 
sc325D6 37 1 101.18 101.18 
sc325D8 37 1 130.77 130.77 
sc325D9 37 1 126.92 126.92 
















107.6 ± 9.7 















97.5 ± 12.4 
594rpoB-(D10) 
[pcIpR-P-timm] 
37 1 49.47 49.47 
 
a
 0.1 ml of the diluted P amber mutant phage was added to 0.3 ml of host cells. Then, 3 ml of 
tryptone top agar was added to the cell-phage mixture and the whole mixture was immediately 
poured onto a rich TB plate. % efficiency of plating of P amber mutant phage on all host strains 
was calculated w.r.t. P amber mutant phage titer on suppressor strain, TC600. % efficiency of 
plating of P amber mutant phage = (Titer (pfu/ml) of P amber mutant phage on a host cell / Titer 
(pfu/ml) of P amber mutant phage on TC600) x 100. 
b
 Standard error has been calculated by taking 2 sets of data into consideration. 
c









Supplemental Figure 1. λimm434Pam3 plaques on 594[pcIpR-P-timm] cell lawn  
    A                                                                       B 
                            
 
Supplemental Figure 1. λimm434Pam3 plaques on 594[pcIpR-P-timm] cell lawn. (A) Marker 
rescue resulting in very small plaque formation on 594[pcIpR-P-timm] cell lawn at 25°C (plating 
dilution: 10-3). 594[pcIpR-P-timm] did not complement for P at 25°C. (B) As 594[pcIpR-P-
timm] cells complemented for P at 37°C, λimm434Pam3 plaques grew on the cell lawn (plating 
dilution: 10-7). P expression from the plasmid complemented for the nonsense mutation in P gene 
in λimm434Pam3 phage allowing plaque formation. The cell lawn was weaker at 37°C (in 









APPENDED SUPPORTING EXPERIMENTAL DATA TABLES: 
 
Supplemental Table 2. P expression at 42°C (from a cryptic λ prophage) kills host E. coli 
cells and P-DnaB interaction is required for P-killing (Data for Figure 5 in Section 3.1a) 
 
Strain Experiment # Viability at 42°C w.r.t. 
30°C a 
Mean ± Standard error 
1 3.0 x 10-6 
2 1.5 x 10-6 
3 4.8 x 10-6 
4 1.7 x 10-5 
5 1.1 x 10-5 
6 1.3 x 10-5 
7 1.7 x 10-5 
8 8.7 x 10-7 
9 1.3 x 10-6 
10 3.9 x 10-6 
11 6.3 x 10-6 
Y836 
12 4.5 x 10-6 
7.0 x 10-6 ± 1.7 x 10-6 
1 1.3 x 10-5 
2 1.7 x 10-5 
3 1.5 x 10-5 
Y836his+ 
4 1.3 x 10-5 
1.45 x 10-5 ± 9.6 x 10-7 
1 0.39 Y836dnaBgrpD55 
2 0.13 




1 2.6 x 10-5 
2 1.8 x 10-5 
3 6.5 x 10-6 
594::(cIII-ren)λ 
4 7.9 x 10-5 










0.26 ± 0.12 
1 6.2 x 10-5 
2 3.7 x 10-4 
3 1.2 x 10-3 
4 3.7 x 10-4 
5 7.0 x 10-4 
6 2.0 x 10-4 
7 2.4 x 10-4 
8 1.4 x 10-5 
Y836 ilr O223aP+ 
9 3.4 x 10-4 







Y836 ilr O+P::IS2 
6 0.15 








7 9.5 x 10-3 






0.223 ± 0.099 
 
a Assay cells were washed and the cell pellets were resuspended in Φ80 buffer and were diluted. 
The diluted cells were plated on rich TB plates in duplicates that were incubated at 30°C and 
42°C. Viability at 42°C w.r.t. 30°C = Cell titer on rich TB plates at 42°C / Cell titer on rich TB 




Supplemental Table 3. P expression at 37°C (from a ColE1 plasmid) kills host E. coli cells 
and P-DnaB interaction is required for P-killing (Data for Figure 6 in Section 3.1b) 
 














Mean viability at 37°C 
w.r.t. 25°C ± Standard 
error 
1 1.2 0.013 
2 0.79 2.0 x 10-3 
3 1.1 9.4 x 10-3 
4 1.1 9.1 x 10-4 
5 0.73 1.1 x 10-3 
6 0.90 c 2.7 x 10-3 
7 0.64 < 7.1 x 10-
4
 
8 1.1 1.7 x 10-3 






0.0043 ± 0.0016 
 
(less than value not taken 
into account) 
1 0.95 1.1 
2 1.3 1.0 
3 0.78 0.50 
4 0.96 0.69 







0.81 ± 0.11 
 105 
7 0.71  
8 1.1  
9 0.94  
 
a
 Assay cells were washed and the cell pellets were resuspended in Φ80 buffer and were diluted. 
The diluted cells were plated on rich TB plates that were incubated at 25°C, 30°C and 37°C. 
Viability at 30°C w.r.t. 25°C = Cell titer on rich TB plates at 30°C / Cell titer on rich TB plates at 
25°C. 
b
 Assay cells were washed and the cell pellets were resuspended in Φ80 buffer and were diluted. 
The diluted cells were plated on rich TB plates that were incubated at 25°C, 30°C and 37°C. 
Viability at 37°C w.r.t. 25°C = Cell titer on rich TB plates at 37°C / Cell titer on rich TB plates at 
25°C. 
c





























Set # / 
exposure 
time at 37°C 
for plates to 
be shifted a 





  10-4 10-5 10-6 10-7   
25 #1    193 e 1.93 x 109 100 
#1    138 e 30 
#2    179 e 
1.59 x 109 100 
37 #1  48 d 9 d  6.9 x 106 0 
1 hour TNTC  TNTC e 162 1.62 x 109 100 
2 hours TNTC TNTC e difficult to 
count as a 
lot of 
colonies 
are fused e 
72 e 7.2 x 108 100 
37→30 








(9 big and 
4 small) 
 1.27 x 107 63 f 
 
a
 A volume of stationary phase cells of 594[pcIpR-P-timm] were washed and the cell pellet was 
resuspended in the same volume of Φ80 buffer. The diluted cells were plated on TB plates that 
were incubated at 25°C, 30°C and 37°C (controls). 3 sets of plates were also plated with the 
same cells at 37°C which after 1, 2 and 6 hours, respectively were cooled on ice for a while and 
were then shifted to 30°C. 
 107 
b
 Average titer (cells/ml) is the cfu count on rich TB plates obtained at each temperature. 
c
 Cfu obtained at different temperatures on rich TB plates were picked with a sterile toothpick 
and stabbed onto a rich TB plate supplemented with ampicillin at a final concentration of 
50µg/ml and a TB control plate. The stabbed plates were incubated at 25°C. % plasmid retention 
among cfu that arose at a particular temperature = (Number of cfu that were able to grow on 
TB+Amp plates / Total number of cfu stabbed) x 100. 
d
 Same sized colonies - quite big. 
e
 Same or similar sized colonies. 




















Supplemental Table 5. Linkage between cryptic λ prophage induction and appearance of 




No. of colonies 
picked up from 







No. of colonies 
picked up from 






Y836 520 0 707 34 
Y836 O+P::Kan 324 0 716 0 
594::(cIII-ren)λ  347 0 295 47 
Y836dnaBgrpD55 179 0 337 11 
Y836 ilr 534c O+P+ 167 0 875 1 
Y836 ilr O208b P+ 322 0 1065 1 
Y836 ilr O223a P+ 223 0 654 11 c 
Y836 ilr O+P::IS2 140 0 503 0 
594dnaBgrpD55 d 413 0 919 1 
594 d 551 0 260 0 
 
a
 To determine whether spontaneous auxotrophs arise within assay cells at 30°C, the 30°C cfu 
were picked with a sterile toothpick and stabbed onto a MM agar plate and a rich TB control 
plate. All plates were incubated at 30°C.  
b
 Survivor cfu at 42°C on TB plates were picked with a sterile toothpick and were stabbed to 
duplicate MM agar plates that were incubated at 30°C and 42°C and a TB control plate incubated 
at 30°C. Inability of a colony to grow on MM plate suggests that the stabbed colony is an 
auxotroph. 
 109 
c Refer to Supplemental Figure 2 for auxotrophic phenotype. 
d
 These assay strains do not have a cryptic λ fragment. 
Note: Y836 is a his- strain. Any derivatives or mutants of Y836 are also his-. Therefore, for 
plating these strains, MM agar plates supplemented with histidine at a final concentration of 0.1 
mg/ml was used. 
 
Supplemental Figure 2. Auxotrophy assessment of Y836 ilr O223a P+ mutants 
                                                                 Rich TB at 30°C 
 
                                           MM+his at 30°C            MM+his+bio at 30°C 
 
Supplemental Figure 2. Auxotrophy assessment of Y836 ilr O223a P+ mutants. 5 auxotrophic 
mutants did not grow on MM+his and MM+his+bio plates at 30°C which suggested that they 
were not biotin auxotrophs. The mutation was in some other nutrient gene. If by chance, they are 
bio-, they are also defective in some other nutrient gene. 
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Supplemental Table 6. P-DnaB interaction is essential for the apparent mutator phenotype 
– P expression from cryptic λ prophage (Data for Figure 10 in Section 3.5) 
 
Strains Experiment # RifR frequency at: Mean ± Standard error 
 
 
30°C a 42°C  b 30°C 42°C 
1 3 x 10-8 Not finite c 
2 5.2 x 10-8 2.94 x 10-2 Y836 
3 4.8 x 10-8 Not finite c 
4.33 x 10-8 ± 6.8 
x 10-9  
2.94 x 10-2 
 
1 9.6 x 10-8 2.4 x 10-7 
2 2.2 x 10-8 2.5 x 10-8 
Y836 O+P::Kan 
3 4 x 10-8 6.66 x 10-7 
5.3 x 10-8 ± 2.2 x 
10-8 
3.1 x 10-7 ± 1.9 
x 10-7 
1 2.25 x 10-7 4.52 x 10-7 
2 1.42 x 10-7 Not finite c 
3 1.44 x 10-7 6.12 x 10-7 
Y836dnaBgrpD55 
4 4 x 10-8 9.3 x 10-8 
1.38 x 10-7 ± 3.8 
x 10-8 
 




1 1.2 x 10-8 Not finite c 
2 1.86 x 10-7 2.67 x 10-4 
3 1.6 x 10-8 2.5 x 10-4 
Y836 ilr O223aP+ 
4 1.27 x 10-7 3.91 x 10-5 
8.5 x 10-8 ± 4.3 x 
10-8 
1.85 x 10-4 ± 7.3 
x 10-5 
 
1 3.9 x 10-8 7.6 x 10-8 
2 3.4 x 10-8 5.8 x 10-8 
Y836 ilr O+P::IS2 
3 1.2 x 10-8 1.38 x 10-7 
2.83 x 10-8 ± 8.3 
x 10-9 




 Assay cells were diluted and plated on TB plates supplemented with rifampicin at a final 
concentration of 100µg/ml and control TB plates at 30°C. RifR frequency at 30°C = Titer on 
TB+Rif at 30°C / Titer on TB at 30°C. 
b
 Assay cells were diluted and plated on TB plates supplemented with rifampicin at a final 
concentration of 100µg/ml and control TB plates at 42°C. RifR frequency at 42°C = Titer on 
TB+Rif at 42°C / Titer on TB at 42°C. 
c
 Frequency values are not finite because no cfu grew on the lowest dilution plate used. 
 
Supplemental Table 7. P-DnaB interaction is essential for the apparent mutator phenotype 
– P expression from a ColE1 plasmid (Data for Figure 11 in Section 3.6) 
Strains Experiment # RifR frequency at: Mean ± Standard error 
  
25°C a 30°C b 37°C c 25°C 30°C 37°C 
1 1.3 x 10-8 1.2 x 10-8 1.72 x 10-6  
2 1.3 x 10-8 1.6 x 10-8  
3 6 x 10-9 3.6 x 10-8 5 x 10-6 
4 3 x 10-8 8 x 10-8 2 x 10-5 
5 3 x 10-8   




7 6 x 10-9 2.2.x 10-8 2.22 x 10-5 
1.5 x 10-8 ± 
4.0 x 10-9 
3.0 x 10-8 




 ± 5.2 x 
10-6 
1 2.7 x 10-8 1.4 x 10-8 2.5 x 10-8 
2 Not finite d 7 x 10-9 5.82 x 10-7 
3 Not finite d 1.6 x 10-8 7.7 x 10-8 





5 8 x 10-9 1.6 x 10-8 3.2 x 10-8 
1.87 x 10-8 ± 
5.6 x 10-9 
 
1.33 x 
10-8 ±  
2.1 x 10-9 
 
1.5 x 10-7 






 Assay cells were diluted and plated on TB plates supplemented with rifampicin at a final 
concentration of 100µg/ml and control TB plates at 25°C, 30°C and 37°C. RifR frequency at 
25°C = Titer on TB+Rif at 25°C / Titer on TB at 25°C. 
b
 Assay cells were diluted and plated on TB plates supplemented with rifampicin at a final 
concentration of 100µg/ml and control TB plates at 25°C, 30°C and 37°C. RifR frequency at 
30°C = Titer on TB+Rif at 30°C / Titer on TB at 30°C. 
c
 Assay cells were diluted and plated on TB plates supplemented with rifampicin at a final 
concentration of 100µg/ml and control TB plates at 25°C, 30°C and 37°C. RifR frequency at 
37°C = Titer on TB+Rif at 37°C / Titer on TB at 37°C. 
d


















Supplemental Table 8. P-DnaB interaction is essential for the apparent mutator phenotype 
– Assay of various plasmid-containing strains (Data for Figure 12 in Section 3.7) 
 
 In order to determine whether P requires DnaB for the potential mutator phenotype 
observed (Section 3.7), P, Ppi or ∆P-expression plasmid-containing cells expressing wild-type 
DnaB or DnaBgrpD55 were assayed to obtain rifR frequencies at 25°C, 30°C and 37°C. 
(Supplemental Table 8 is a combination of Supplemental Tables 9 and 10.) 
 





25°C a 30°C b 37°C c 25°C 
d
 
30°C e 37°C f 
 
594[pcIpR-P-timm] 1.5 x 10-8 ± 4.0 
x 10-9 
3.0 x 10-8 ± 
1.1 x 10-8 
1.22 x 10-5 ± 
5.2 x 10-6 




1.87 x 10-8 ± 5.6 
x 10-9 
1.33 x 10-8 
± 2.1 x 10-9 
1.5 x 10-7 ± 
1.1 x 10-7 
1.0 0.71 8.0 5 
594[pcIpR-P
pi






3.5 x 10-8 Not finite g 4.2 x 10-7 1.0 Not finite g 12 1 
594[pcIpR-∆P-
timm] 
5.2 x 10-8 4.3 x 10-8 ± 
1.4 x 10-8 




Not finite g 2 x 10-9 9.5 x 10-9 ± 
5.5 x 10-9 





 Mean rifR frequency values and standard errors have been tabulated. RifR frequency at 25°C = 
Titer on TB+Rif at 25°C / Titer on TB at 25°C. 
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b
 Mean rifR frequency values and standard errors have been tabulated. RifR frequency at 25°C = 
Titer on TB+Rif at 30°C / Titer on TB at 30°C. 
c
 Mean rifR frequency values and standard errors have been tabulated. RifR frequency at 25°C = 
Titer on TB+Rif at 37°C / Titer on TB at 37°C. 
d
 Fold change in rifR frequency at 25°C = RifR frequency at 25°C / RifR frequency at 25°C. 
e
 Fold change in rifR frequency at 30°C w.r.t. 25°C = RifR frequency at 30°C / RifR frequency at 
25°C. 
f
 Fold change in rifR frequency at 37°C w.r.t. 25°C = RifR frequency at 37°C / RifR frequency at 
25°C. 
g
 Frequency and fold change values are not finite because no cfu grew on the lowest dilution 
plate used. 
Note: Figure 12 contains fold change values at 25°C and 37°C. Data for 














Supplemental Table 9. P-DnaB interaction is essential for the apparent mutator phenotype 
– Assay of various plasmid-containing strains (Data for Figure 12 in Section 3.7) 
 
Strains Expt. # RifR frequency at: Mean ± Standard error 
  
25°C a 30°C b 37°C c 25°C 30°C 37°C 
1 1.3 x 10-8 1.2 x 10-8 1.72 x 10-6 
2 1.3 x 10-8 1.6 x 10-8  
3 6 x 10-9 3.6 x 10-8 5 x 10-6 
4 3 x 10-8 8 x 10-8 2 x 10-5 
5 3 x 10-8   
6 7 x 10-9 1.1 x 10-8  
594[pcIpR
-P-timm] 
7 6 x 10-9 2.2.x 10-8 2.22 x 10-5 
1.5 x 10-8 ±  
4.0 x 10-9 
3.0 x 10-8 ±  





1 2.7 x 10-8 1.4 x 10-8 2.5 x 10-8 
2 Not finite d 7 x 10-9 5.82 x 10-7 
3 Not finite d 1.6 x 10-8 7.7 x 10-8 







5 8 x 10-9 1.6 x 10-8 3.2 x 10-8 
1.87 x 10-8 ± 
5.6 x 10-9 
 
1.33 x 10-8 
±  
















1 3.5 x 10-8 > 3.5 x 10-8 4.2 x 10-7 3.5 x 10-8 Not finite d 4.2 x 
10-7 
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1  Not finite d 5 x 10-8 Not finite d 
2 Not finite d 1.6 x 10-8 Not finite d 
594[pcIpR
-∆P-timm] 
3 5.2 x 10-8 6.2 x 10-8 3.33 x 10-7 
5.2 x 10-8 
 
4.3 x 10-8 ±  










2 Not finite d 2 x 10-9 4 x 10-9 








 Assay cells were diluted and plated on TB plates supplemented with rifampicin at a final 
concentration of 100µg/ml and control TB plates at 25°C, 30°C and 37°C. RifR frequency at 
25°C = Titer on TB+Rif at 25°C / Titer on TB at 25°C. 
b
 Assay cells were diluted and plated on TB plates supplemented with rifampicin at a final 
concentration of 100µg/ml and control TB plates at 25°C, 30°C and 37°C. RifR frequency at 
30°C = Titer on TB+Rif at 30°C / Titer on TB at 30°C. 
c
 Assay cells were diluted and plated on TB plates supplemented with rifampicin at a final 
concentration of 100µg/ml and control TB plates at 25°C, 30°C and 37°C. RifR frequency at 
37°C = Titer on TB+Rif at 37°C / Titer on TB at 37°C.  
d
 Frequency values are not finite because no cfu grew on the lowest dilution plate used. 
e






Supplemental Table 10. P-DnaB interaction is essential for the apparent mutator 
phenotype – fold change values (Data for Figure 12 in Section 3.7) 
 
Fold changes in rifR frequencies at Strains 
25°C a 30°C b 37°C c 
594[pcIpR-P-timm] 1.0 2.0 810 
594dnaBgrpD55malF3089::Tn10 
[pcIpR-P-timm] 
1.0 0.71 8.0 
594[pcIpR-Ppi-timm] 1.0 4.1 25 
594dnaBgrpD55malF3089::Tn10 
[pcIpR-Ppi-timm] 
1.0 Not finite d 12 
594[pcIpR-∆P-timm] 1.0 0.82 6.4 
594dnaBgrpD55malF3089::Tn10 
[pcIpR-∆P-timm] 
1.0 Not finite d Not finite d 
 
a
 Fold change in rifR frequency at 25°C = RifR frequency at 25°C / RifR frequency at 25°C. 
b
 Fold change in rifR frequency at 30°C w.r.t 25°C = RifR frequency at 30°C / RifR frequency at 
25°C. 
c
 Fold change in rifR frequency at 37°C w.r.t 25°C = RifR frequency at 37°C / RifR frequency at 
25°C. 
d
 Fold change values are not finite because frequencies were not finite as no cfu grew on the 




Supplemental Table 11. RifR cfu (at 10-1 plating dilution) from starting rifS 594[pcIpR-P-
timm] cells selected on TB+100µg/ml Rif at 25°C (Data for Figure 13A in Section 3.8) 
 
 In Low Dose Inoculum Assay (Section 3.8), the number of rifR cfu that grew from each 
culture tube (A1-A10, B1-B10, C1-C10 and D1-D10) at 25°C has been tabulated in 
Supplemental Table 11. 
 
 A B C D 
1 0 6 a 0 1 
2 #1 – 0 
#2 – 0 
#3 – 0 
1 0 2 
3 0 1 0 0 
4 #1 – 3 
#2 – 0 
0 #1 – 2 
#2 – 2 
5 
5 #1 – 0 
#2 – 0 
0 #1 – 1 
#2 – 2 
1 
6 1 4 #1 – 7 
#2 – 4 
6 
 
7 #1 – 2 
#2 – 3 
0 1 0 
8 0 0 0 #1 – 1 
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#2 – 1 
9 1 
 
0 0 #1 – 0 
#2 – 1 
10 1 #1 – 0 





 RifR cfu obtained on TB+Rif plates at 25°C from Tube B1 or Culture # 11 (in Figure 13A). 15 
cells of 594[pcIpR-P-timm] sc 3 were added to each of 40 tubes containing 1 ml rich TB broth 
and all 40 inoculated cultures were grown at 25°C for 48 hours to stationary phase. 0.1 ml cell 
aliquots from each of the 40 tubes were plated on two rich TB plates supplemented with 
rifampicin at a final concentration of 100µg/ml. One plate was incubated at 25°C and the other at 
37°C. #1, #2 and #3 refers to plates in duplicates or triplicates.  
 
Note: In graph (Figure 13A), tube A1 refers to Culture 1, tube A2 refers to Culture 2, tube A3 










Supplemental Table 12. RifR cfu (at 10-1 plating dilution) from starting rifS 594[pcIpR-P-
timm] cells selected on TB+100µg/ml Rif at 37°C (Data for Figure 13B in Section 3.8) 
 
 In Low Dose Inoculum Assay (Section 3.8), the number of rifR cfu that grew from each 
culture tube (A1-A10, B1-B10, C1-C10 and D1-D10) at 37°C has been tabulated in 
Supplemental Table 12. 
 
 A B C D 
1 0 2 2 a 1 
2 0 0 16 1 
3 0 0 36 7 
4 0 0 1 2 




6 0 0 1 2 
7 1 0 9 2 
8 6 2 2 0 
9 4 1 0 1 
10 6 0 0 0 
 
a
 RifR cfu obtained on TB+Rif plates at 37°C from Tube C1 or Culture # 21 (in Figure 13B). 15 
cells of 594[pcIpR-P-timm] sc 3 were added to each of 40 tubes containing 1 ml rich TB broth 
 121 
and all 40 inoculated cultures were grown at 25°C for 48 hours to stationary phase. 0.1 ml cell 
aliquots from each of the 40 tubes were plated on two rich TB plates supplemented with 
rifampicin at a final concentration of 100µg/ml. One plate was incubated at 25°C and the other at 
37°C. 
Note: In graph (Figure 13B), tube A1 refers to Culture 1, tube A2 refers to Culture 2, tube A3 
refers to Culture 3 and so on. 
 
Supplemental Table 13. RifR cfu (at 10-1 plating dilution) from starting rifS 594 cells 
selected on TB+100µg/ml Rif at 25°C (Data for Figure 13A in Section 3.8) 
 
 In Low Dose Inoculum Assay (Section 3.8), the number of rifR cfu that grew from each 
culture tube (B, C, D and E) at 25°C has been tabulated in Supplemental Table 13. 
 
 B C D E 
Set 1 0 0 0 1 a 
Set 2 0 0 0 0 
 
a
 RifR cfu obtained on TB+Rif plates at 25°C from Tube E or Culture # 44 (in Figure 13A). 19 
594 cells were added to each of 4 tubes containing 1 ml rich TB broth and all 4 inoculated 
cultures were grown at 25°C for 48 hours to stationary phase. 0.1 ml cell aliquots from each of 
the 4 tubes were plated on two rich TB plates supplemented with rifampicin at a final 
concentration of 100µg/ml. One plate was incubated at 25°C and the other at 37°C.  
Note: In graph (Figure 13A), tube B refers to Culture 41, tube C refers to Culture 42, tube D 
refers to Culture 43 and tube E refers to Culture 44. Set 1 and Set 2 are duplicate platings of cells 
from the same tube. 
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Supplemental Table 14. RifR cfu (at 10-1 plating dilution) from starting rifS 594 cells selected on 
TB+100µg/ml Rif at 37°C (Data for Figure 13B in Section 3.8) 
 
 In Low Dose Inoculum Assay (Section 3.8), the number of rifR cfu that grew from each 
culture tube (B, C, D and E) at 37°C has been tabulated in Supplemental Table 14. 
 
 B C D E 
Set 1 0 0 1 a 0 
Set 2 0 0 0 0 
 
a
 RifR cfu obtained on TB+Rif plates at 37°C from Tube D or Culture # 43 (in Figure 13B). 19 
594 cells were added to each of 4 tubes containing 1 ml rich TB broth and all 4 inoculated 
cultures were grown at 25°C for 48 hours to stationary phase. 0.1 ml cell aliquots from each of 
the 4 tubes were plated on a rich TB plate supplemented with rifampicin at a final concentration 
of 100µg/ml at 25°C and 37°C.  
Note: In graph (Figure 13B), tube B refers to Culture 41, tube C refers to Culture 42, tube D 
refers to Culture 43 and tube E refers to Culture 44. Set 1 and Set 2 are duplicate platings of cells 
from the same tube. 
 
